Precancerous diseases  of maxillofacial area by Аветіков, Давид Соломонович et al.
0 
 
 
 
 
 
 
 
 
 
PRECANCEROUS DISEASES  
OF MAXILLOFACIAL AREA 
 
Text book  
  
 
 
 
 
 
 
 
 
 
 
 
 
Poltava – 2017 
1 
 
МІНІСТЕРСТВО ОХОРОНИ ЗДОРОВ’Я УКРАЇНИ 
ВИЩИЙ ДЕРЖАВНИЙ НАВЧАЛЬНИЙ ЗАКЛАД УКРАЇНИ 
«УКРАЇНСЬКА МЕДИЧНА СТОМАТОЛОГІЧНА АКАДЕМІЯ» 
 
 
 
 
АВЕТІКОВ Д.С., АЙПЕРТ В.В., ЛОКЕС К.П. 
 
AVETIKOV D.S., AIPERT V.V., LOKES K.P. 
 
 
 
Precancerous diseases  
of maxillofacial area 
 
ПЕРЕДРАКОВІ ЗАХВОРЮВАННЯ 
ЩЕЛЕПНО-ЛИЦЕВОЇ ДІЛЯНКИ 
 
 
Навчальний посібник 
Text-book 
 
Полтава – 2017 
Poltava – 2017 
  
2 
 
UDK 616.31-006 
BBC 56.6 
A 19 
It is recommended by the Academic Council of the Higher state educational 
establishment of Ukraine "Ukrainian medical stomatological academy" as a 
textbook for English-speaking students of higher education institutions of the 
Ministry of Health of Ukraine (Protocol № 3, 22.11.2017). 
Writing Committee 
D.S. Avetikov – doctor of medicsl science, professor, chief of department of 
surgical stomatology and maxillo-facial surgery with plastic and 
reconstructive surgery of head and neck of the Higher state educational 
establishment of Ukraine ―Ukrainian medical stomatological academy‖. 
V.V. Aipert – candidate of medical science, assistant professor of department 
of surgical stomatology and maxillo-facial surgery with plastic and 
reconstructive surgery of head and neck of the Higher state educational 
establishment of Ukraine ―Ukrainian medical stomatological academy‖  
K.P. Lokes - candidate of medical science, associate professor of department 
of surgical stomatology and maxillo-facial surgery with plastic and 
reconstructive surgery of head and neck of the Higher state educational 
establishment of Ukraine ―Ukrainian medical stomatological academy‖ 
Reviewers: 
R. Z. Ogonovski, doctor of medicsl science, professor, chief of department of 
surgical stomatology and maxillo-facial surgery ―Lviv national medical 
university named of D.Galicky‖.       
Y.P. Nagirny, doctor of medicsl science, professor, chief of department of 
surgical stomatology ―Ternopol state medical university named of  
І.Y. Gorbachevsky‖ 
The publication on the achievements of modern medicine covered issues of 
etiology, pathogenesis, clinical manifestations, diagnosis and treatment of 
precancerous diseases of maxillofacial area. The classification of 
precancerous lesions, which are used both by as dentists and oncologists. 
One of the sections is dedicated to the organization of cancer services in 
Ukraine, organization of cancer care to people in Ukraine. The problems of 
periodic screening, prophylactic medical examination service, oncological 
alertness are covered. The manual can be useful for students of dental and 
medical faculties, interns, medical residents, dentists, family doctors, 
oncologists and other doctors. 
  
3 
 
УДК 616.31-006 
ББК 56.6 
A 19 
Рекондовано вченою радою Вищого державного навчального 
закладуУкраїни «Українська медична стоматологічна академія» як 
навчальний посібник для англомовних студентів вищих навчальних 
закладів МОЗ України (Протокол №3 від 22.11.2017 р.) 
 
Автори: 
Д.С. Аветіков – доктор медичних наук, професор, завідувач кафедри 
хірургічної стоматології та щелепно-лицевої хірургії з пластичною та 
реконструктивною хірургією голови та шиї Вищого державного 
навчального закладу України «Українська медична стоматологічна 
академія». 
В.В. Айперт – кандидат медичних наук, асистент кафедри хірургічної 
стоматології та щелепно-лицевої хірургії з пластичною та 
реконструктивною хірургією голови та шиї Вищого державного 
навчального закладу України «Українська медична стоматологічна 
академія».  
К.П. Локес – кандидат медичних наук, доцент, доцент кафедри 
хірургічної стоматології та щелепно-лицевої хірургії з пластичною та 
реконструктивною хірургією голови та шиї Вищого державного 
навчального закладу України «Українська медична стоматологічна 
академія». 
Reviewers: 
Р.З. Огоновський – доктор медичних наук, професор, завідувач 
кафедри хірургічної стоматології та щелепно-лицевої хірургії 
Львівського національного медичного університету ім. Д. Галицького  
Ю.П. Нагірний – доктор медичних наук, професор, завідувач кафедри 
хірургічної стоматології Тернопільського державного медичного 
університету ім. І.Ю. Горбачевського. 
У даному виданні висвітлені досягнення сучасної медицини, питання 
етіології, патогенезу, клінічних проявів, діагностики та лікування 
передракових захворювань щелепно-лицевої ділянки. Класифікація 
предраковых уражень, які використовуються як стоматологами, так і 
онкологами. 
Один із розділів присвячений організації онкологічної допомоги в 
Україні. Обговорюються проблеми періодичного скринінгу, служби 
профілактичної медичної експертизи, онкологічної перестороги. 
Посібник призначений для студентів стоматологічних та медичних 
факультетів, лікарів-інтернів, клінічних ординаторів, стоматологів, 
сімейних лікарів, онкологів та лікарів інших спеціальностей. 
  
4 
 
 
CONTENT 
 
Introduction 
Section I 
Cancer care organization to popultion in Ukraine  
Malignant tumors epidemiology 
Section II 
Population preventive examinations 
Cancer patients examination methods and malignant tumors diagnosis 
principles  
Maxillofacial precancerous conditions. Precancer concept  
Precancer provoking factors 
Precancer classification 
Obligate precancers 
Optional pre-cancerous diseases with great potential malignancy  
Optional pre-cancerous diseases with less potential malignancy 
Precancerous diseases of face skin 
Optional precancerous skin diseases 
Section III 
Applicability of phototherapy by device «UFL-122» in combination with gel 
"solcoseryl" for the treatment of precancerous lesions of the oral mucosa and 
lips (erosion, fissures, ulcers that prolonged healing). 
Prospects of optimizing of the diagnosis and treatment of precancerous 
diseases of the mucous membrane of the oral cavity. Treatment. Prevention. 
Oral cavity precancerous states and cancer histological diagnostic 
objectification by biomarkers P-53 and KI-67 on biopsy material 
Literature 
 
  
5 
 
INTRODUCTION 
 
 
 The problem of cancer, especially malignant tumors is one of the 
most pressing of modern medicine. According to WHO, each year nearly 4.3 
million people dies from cancer in the world. Cancer is among the three 
leading causes of death in all age groups after 50 years - both in developed 
countries and those are in developing. 
 Malignant tumors of the head and neck (excluding skin, eyes and 
brain) constitute about 5% of cancers of other locations.Among head and 
neck malignant tumors cancer of the oral cavity and oropharynx is on 
second place after the cancer of the larynx, and their ratio is 2 - 10% of all 
human cancers.  
Oral cancer is a major health problem in tobacco users all over the 
world. It is one of the ten most common cancers in the world. Oral cancer is 
almost always preceded by some type of precancerous lesion. The 
precancerous lesions can be detected upto 15years, prior to their change to an 
invasive carcinoma. It usually affects between the ages of 15 and 40 years. It 
may be triggered by factors like frequency and duration of tobacco 
consumption, alcohol, poor oral hygiene etc. 
However, this number of patients find significant because the 
disease leads to extremely severe dysfunction breathing, swallowing, 
speech and appearance. In these patients serious condition are due, 
primarily to advanced and often incurable forms of disease, while 
advanced forms of cancer other locations lead to death from certain 
metastasis. 
Oral cancer ranks as the sixth most common malignancy worldwide, 
90% of which consists of squamous cell carcinoma. Morbidity and mortality 
have not decreased over the past 50 years. Oral cancer early detection, mainly 
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that of squamous cell carcinoma, is crucial to improve the patient’s survival 
rate. The clinical diagnosis of oral precancerous lesions, leukoplakias and 
erythroplakias, is one of exclusion. The lesions to be excluded are those 
belonging to other conditions, such as lichen planus (acknowledging that it 
has a malignant potential itself), lupus erythematosus, leukoedema, white 
sponge nevus, and other lesions for which an etiology can be established, such 
as frictional keratosis, cheek/lip/tongue biting, contact lesions, and smoker's 
palate. In many cases, a biopsy is mandatory so that such lesions can be 
discarded. Currently, histological criteria (dysplasia presence and degree) 
represent the gold standard in precancerous lesion risk evaluation. 
 
 
  
7 
 
SECTION I 
 
CANCER CARE ORGANIZATION TO POPULTION IN 
UKRAINE  
 
 
 Fighting malignant tumors is a major public health problem in Ukraine. 
The urgency of this matter is being identified by the constant growth of 
malignant tumors among the population, early diagnosis difficulties, high cost 
and difficulty of treatment, high disability and mortality rate of patients. 
 Each year about 200,000 new cases of malignant tumors are recorded in 
Ukraine. Medical and social significance feature of malignancies caused the 
implementation of the state system of cancer care.  
 Specialized cancer care is the system of measures for cancer 
diagnostics, treatment and rehabilitation of cancer patients, tracking the 
population with  malignancies cases. 
 The basis of cancer care providing to patients is the principle of 
dispensary service, which is the active dynamic monitoring of the health of 
patients and provide them with necessary medical and diagnostic care. 
 Ukraine has a unique system of oncological service that has national, 
regional and peripheral level. The position of chief oncologist who heads the 
organizational and methodical measures undertaken within the country is 
provided in the Ministry of Health of Ukraine. 
  Methodical supervision for oncological care of Ukraine is porvided by 
Ukrainian Research Institute of Oncology and Radiology. 
Regional Oncology Centers (ROC) - specialized health care institutions 
to provide cancer care to the people are  operating in the regional centers. The 
main objectives of ROC are as follows: 
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– qualified specialized polyclinic and hospital, consulting and 
medical assistance to the population in full volume providing 
according to the standard schemes; 
– monitoring the quality of implementation of treatment in medical 
institutions permitted to treat cancer patients; 
– organizational guidance and monitoring of timely diagnosis of 
malignant neoplasms in all health care settings common network 
in their regions, as well as studying the causes of late diagnosis; 
– organizational and methodic supervision and monitoring of timely 
diagnosis of malignant neoplasms in all common network health 
care centers in their regions, as well as studying the causes of late 
diagnosis; 
– increase cancer knowledge through specialization and training of 
oncological healthcare personnel; 
– Implementation in practice of modern methods of diagnosis and 
treatment of cancer, an analysis of the effectiveness of treatment in 
all health care centers; 
– implementation and provision of full tracking of cancer patients in 
the region, systematic analysis of morbidity and mortality in the 
region, analysis of advanced forms of the disease, determine the 
causes of late diagnosis and the development of measures to their 
elimination; 
– providing clinical supervision for cancer patients; 
– preventive examinations of the population to identify primary 
cancer patients; 
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– expended health education work providing among all strata of the 
population explaining the benefits of cancer treatment in the early 
stages. 
 
 Typically, the Regional Oncology Center include organizational and 
methodological department, outpatient department, outpatient, specialized 
clinical departments: surgery, radiology, gynecology, department of head and 
neck tumors, chemotherapy and others. In addition, the clinics provided the 
X-ray department and radionukleidnoyi diagnostics, endoscopic, ultrasound 
diagnostics, clinical and cytological laboratory and others. The ROC houses 
Oncology Departments. Such ROC are called Clinical.  
 The Department together with basic ROC implementing large-scale 
development plans oncology science and practice, train students and improve 
knowledge on medical oncology, provide adequate professional level basic 
institutions adopting the practice of cancer science achievement and conduct 
research. 
 Two research institutes with oncological and radiation oncology 
specialization, 45 oncology clinics (including 24 regional, 1 republican level), 
one Cancer Center in the Kyiv city, 699 cancer offices (branches) operated in 
Ukraine in 1996. 
 Ministry of Health of Ukraine believes that the treatment of cancer 
patients (with few exceptions) should be done only in cancer institutions, as 
the complexity of treatment and the need for complex methods applying 
(surgery, radiation, chemotherapy) makes this requirement. It was established 
that the life expectancy of cancer patients treated in ROC in 2.0-2.5 times 
higher the case when treated at the general hospital network. 
Malignant tumors is one of the major biomedical and social and 
economic problems not only in Ukraine but in the world. The incidence and 
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cancer mortality steadily growing, increasing their risk due to the unstable 
economic situation in the country, unfavorable ecological situation and a 
significant aging population. 
Since 1953 in our country compulsory registration of cancer incidence 
and in 1956 population mortality from malignant tumors were introduced. 
The study of malignant tumors distribution among the population features, 
evaluating the effectiveness of anticancer complex measures based on reliable 
data and reliable use of cancer statistics teaching materials, ensuring the 
collection, processing, storage and efficient use of materials morbidity and 
mortality from cancer. 
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MALIGNANT TUMORS EPIDEMIOLOGY 
 
 
Oncologic and epidemiologic situation in Ukraine and in some of their 
regions based on long-term monitoring data is characterized by continuous 
growth of cancer population morbidity. Thus, in 1980 the number of newly 
registered patients was 238.3 per 100,000 population in 1996 this value 
reached 309.4, and in 2010 the incidence of malignant neoplasms in Ukraine 
amounted to 341.2 per 100,000 population. Each year cancer ill more than 
160,000 people. This means that every day in Ukraine arrises 442 new cases 
of cancer or 18 cases per every hour. This figures indicating on the intensity 
and magnitude of the process. The risk of getting cancer throu the life has 
each third or fourth man and every fifth-sixth woman. 
It should be noted that cancer is the cause of more than 15% of all 
deaths in Ukraine, second only to deaths from cardiovascular disease; 35% of 
deaths from malignant tumors - those of working age. 239 people per day or 
10 – hourly die from cancer every day. Over the past 5 years mortality rate 
decreased from 187,4x100000 to 184,5x100000 population, or for 1.6%. 
Malignant tumors are the cause of 21-26% of all disability population. 
Rising incidence typical of cancer and mucosa of the mouth, colon and 
rectum, skin, breast, cervical and uterine, ovarian, prostate, bladder, thyroid, 
lymphatic and hematopoietic tissue. The largest increase (20 - 50%) 
morbidity found in malignant tumors of the prostate, kidney, thyroid, colon 
and rectum, uterine body. 
In the structure of the male population morbidity top 5 places are 
malignant tumors of the lung, stomach, skin, prostate, rectum (52.2% of all 
malignant tumors). 
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In the female population the first five places in the structure of 
morbidity occupy breast cancer, uterine body, colon,  uterine cervix (53.5% of 
all malignant tumors). 
The effectiveness of treatment of malignant tumors in the present 
conditions depends mainly on them early and timely diagnosis. Fatality of 
cancer is to the greatest extent due to its late discovery. However, the 
condition of the diagnosis of malignant tumors remains unsatisfying. Only 22-
25% of patients with cancer of the oral mucosa enter to specialized cancer 
facilities in I-II disease stage. The worse situation is with the identification of 
malignant tumors of the maxillary sinus. According to M.V.Mukhyn, 
B.D.Kabakov, V.S.Protsyk data that not lost relevance until recent time, 
timely diagnosis of these tumors was only in 9.1% of patients. 
Within recent years the development of a computerized information 
processing system of cancer patients (ASOI "Oncology"), which allows time 
and better use of computers based on data as cancer statistics in the field of 
medical services, and in terms of research. 
Thus, oncology service is based on dispensary principle and has strictly 
defined functions and tasks aimed at prevention, diagnosis, treatment and 
rehabilitation of cancer patients as well as clinical supervision for them after 
treatment. 
It should be specially emphasized that taking into account the tense 
oncological situation in Ukraine, to the fight of cancer system should be 
included not only the cancer institutions, but all the medical institutions 
including the dental once as well. 
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SECTION II 
 
POPULATION PREVENTIVE EXAMINATIONS 
 
 
The main factor that determines the success of treatment and favorable 
predicting with tumors of the maxillofacial area is early diagnosis. 
Maxillofacial area has a good availability for examination as by a 
doctor and by the patient. However, tumor symptoms could be so mild 
that the transition of chronic inflammatory or destructive process into 
malignant growth often goes unnoticed either by specialist or patient.  
The large number of neglected cases or absence of cancer suspicion 
is the evidence of the difficulty of diagnosis of cancers initial stages.  
Several authors point out that the lack of different specialties 
doctors (physicians, surgeons, neurologists, optometrists, physicians 
district hospitals) awareness as for the early symptoms of dental 
oncologic diseases in 35.3% is the cause malignant tumors of 
maxillofacial localization neglect, 40.7% - amount dentists and 
otolaryngologists errors, 17.5% of patients who later seek treatment due 
to lack of understanding of the possibility of malignant lesions, often 
engaged in self-treatment cases. 
The most common errors were obzereved in early stages of disease: I 
stage - 43.53%, 52.76% - in stage II. A biopsy and tumors histology were 
done in all patients: clinical diagnosis was not confirmed in 13.53% of 
patients. 
Great importance in the public health system has preventive 
examinations. Comprehensive medical preventive examinations aimed to 
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detect precancerous diseases and malignant tumors. The entire population of 
Ukraine at the age of 20 is subjected to oncologic preventive examinations. 
 
The following survey methods should always be used during preventive 
examinations performing: 
1. Skin and visible mucous membranes examination; 
2. Lymph nodes all groups palpation; 
3. Cytological examination to detect precancerous and malignant 
tumors (if necessary); 
4. Biopsy with histopathological material exanination (if necessary); 
5. Radial methods of examination (X-ray, ultrasound diagnostics, etc.); 
6. Total blood count. 
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CANCER PATIENTS EXAMINATION METHODS AND 
MALIGNANT TUMORS DIAGNOSIS PRINCIPLES  
 
 
During preventive examinations performing to detect precancerous 
diseases and early forms of cancer it is necessary first to conduct the most 
commonly affected with malignant tumors organs examination: the skin of 
face and neck, lips, tongue and oral cavity mucosa. 
When starting the skin examination, pay attention to the cracks that are 
not heal for a long time, ulcers, age spots, the long existing eczematous 
rashes, actively growing warts, nodules, skin indurations - especially 
professional keratoses. Such patients should be detailed examined in 
dermatological hospitals, if necessary - with conducting morphological or 
cytological verification (lupus erythematosus, psoriasis, ichthyosis).  
Dentists during oral cavity preventive examinations performing for the 
purpose of rehabilitation and treatment should pay attention to ulceration of 
the mucous membrane for a long time healing, cracked lips red border, white 
thick, rough patches of the oral mucosa and lips. If unsuccessful treatment of 
these damage elements during 7-10 days doctor must send patients to consult 
a medical oncologist.  
Lips, tongue, oral mucosa examination should start with questioning 
the patient about the presence of his unpleasant, painful sensations, 
particularly while talking and eating. During the physical examination, special 
attention should be paid to those areas where the most commonly 
malignancies are occurred: red border of the lower lip, the side surface of the 
tongue, the root of the tongue, mucous membrane of the floor of the mouth 
and cheeks.  
During a physical examination on the lower lip attention is paid to dry 
red border, its matte surface, epithelium induration, cracks, peeling, presence 
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of cells and rough whitish spots and ulcers, especially with elevated as a roller 
edges. 
During mouth and tongue examination should also pay attention to 
continuously existing erosions, ulcers, fissures, whitish spots, plaques, 
nodules and indurations availability. It is important to determine the size of 
infiltrates around ulcers, soreness and tightness (or indolence) of the mass, its 
displacement relative to surrounding tissue, benign lesion bleeding tissue. 
Oral cavity examination should be performed at a sufficient illumination 
using frontal reflector, binocular magnifier and other tools. It is advisable to 
wider introduce at stomatoscopy methods using oral cavity mucosa vital 
coloring. 
Very valuable diagnostic feature is the mobility of the teeth, which is 
not associated with inflammatory diseases of periodontal and periodontal. 
When having a suspicion for upper jaw tumors the attention is drawn to the 
face asymmetry presence or absence, the presence or absence of deformation 
of the alveolar process and palate, the lower edge of the orbit, changing size 
and shape of the slit eye, exophthalmos. Nasal breathing quality is being 
checked, headaches complaints, nosebleeds, nasal secretions nature are being 
found out. 
Palpable determine the configuration, texture, size of the salivary 
glands, determine the status of their excretory ducts, the nature of the secret. 
A must is to determine the status of regional lymph nodes 
pidpidboridnoyi, submandibular areas along kyvalnyh muscles, and lateral 
carotid triangle of the neck and supraclavicular areas. A must is to determine 
the status of regional lymph nodes sub-mental, submandibular areas along 
Sternocleidomastoid muscle, and lateral carotid triangle of the neck and 
supraclavicular areas. It should be remembered that the cross-metastasis 
(bilateral and contralateral) is often obsereved.  
17 
 
During thyroid gland palpation draw attention to its increase in size, 
gland texture, indurations, nodes presence. In the presence of pathological 
changes ultrasound (US) is necessary, if possible – gland scaning. All nodes 
formation and indurations of thyroid subject to cytology, and puncture to 
obtain material should be done under ultrasound conrtol. 
In the presence of pathological processes in the maxillofacial area 
dentist should take smears of ulcers or make a tumor puncture or enlarged 
lymph nodes for cytology, perform a biopsy. 
 
BIOPSY - lifetime remove a piece of tissue for diagnostic 
histopathological study. This is the most accurate method for diagnosis of 
tumors, particularly in their early stages, biopsy reliability - 80 - 98%. A 
biopsy allows diagnosis and other processes - benign tumors, inflammation, 
hyperplasia formation. A biopsy is necessary to clarify already established 
diagnosis and differential diagnosis performing. Repeated biopsy allows to 
trace the morphological dynamics of pathological process under the influence 
pharmaceuticals and evaluate the effectiveness of treatment.  
 
There are the following forms of biopsy: 
 diagnostic; 
 emergency; 
 accidental. 
 
Biopsy performing methods: 
– incision biopsy – excision of one or more pieces of tumors (when 
tumors are large size). Tissue excision is made with scalpel, electric knife, 
electric snare, conchotome. Excessive anesthetic infiltration of the tumor 
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should be avoided during the biopsy, better to apply general anesthesia. 
Incision biopsy performing requires certain rules:  
– a) a biopsy should be performed at the border of healthy tissue, 
grasping unchanged tissue sa well;  
– b) material with necrotic areas, tumors decay areas should not to 
be taken for the examination;  
– c) in the event of small surface formations better to remove them 
completely (biopsy in toto);  
– d) during electric biopsy extracted piece of tissue should be at 
least 1 cm. 
 
After suspected malignant tumor piece of tissue removing, excision 
area is subjected to electrocoagulation process or treated with 96 % alcohol. 
The dimensions of the removed piece determined depending on the nature and 
location of the pathological focus, it should be sufficient for histopathological 
study.  
During lymph node biopsy should try to remove it or more adjacent 
nodes to each other completely, without breaking the capsule. Gentle care to 
tissue, minimum traumtization of it is the necessary condition of properly 
performed biopsy. Extracted piece of tissue for histological examination 
immersed in fixing solution (10% neutral formaldehyde solution).  
 
Prior to immersion in formaldehyde it is advisable to do from the piece 
surface smears for cytology.  
– excision biopsy – surgical removal of all pathological focus. 
Most often used for skin tumors, enlarged lymph nodes, small lip and oral 
mucosa tumors.  Often excision biopsy is a therapeutic measure. 
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– trepanobiopsy – receiving column tissue using a needle specially 
constructed for this purpose (M.P.Fedyushyna, L.Machulskoho and others). 
Trepanobiopsy can be used in lesions of bone, in lymph nodes dense 
metastases, in hematology for sternal punctures and other examinations.  
– forceps biopsy – obtaining a piece of tissue using various designs 
forceps (conchotomes). It is used within endoscopy in particular. You can use 
examination in the mouth cavity as well. 
Incidental biopsy – the examination, if material is obtained incidentally 
for the patient, for instance, while bronchial tumor piece expectoration. 
Urgent (express biopsy) considered those biopsy aimed to obtaining 
histopathological conclusion within a few minutes after obtaining the 
material. Express biopsy is often performed during surgery to clarify the 
diagnosis and determine further treatment strategy in the short term. 
 
Biopsy is also performed while clinically diagnosed with the aim of: 
– histological confirmation of the diagnosis because the clinical data may 
prove false and lead to unnecessary and sometimes disabling surgery; 
– tumor accurate morphological characteristics obtaining, its histological 
variant formation, the degree of differentiation; 
– tumor determining prevalence both in the affected organ and beyond, 
which enables the rational choice of treatment to be selected; 
– individual malignant tumor sensitivity identification to chemotherapy 
drugs for treatment and selection of the most effective cytotoxic drugs (such 
studies conducted in vitro or in tissue culture using biopsy material); 
– particular treatment type success assessement; 
– tumor recurrence detection or exclusion; 
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– tumor presence documentary evidence, which patient has before was 
treatment, that has except other things the legal significance, if necessary to 
confirm the treatment validity, justified only for malignant tumors; 
– tumors statistics reliability; 
– future malignancies treatment  outcomes prognosis prediction and 
reliable scientific data obtaining. 
 
Being one of the most accurate methods for tumors diagnosis, biopsy is 
still sometimes gives incorrect results due to non-compliance material 
obtaining or morphological sample inaccurate interpretation. In such cases, a 
biopsy should be repeated. 
Bleeding, surrounding tissue damage, wound festering, tumor cells 
dissemination may be biopsy complications. 
 
CYTOLOGICAL EXAMINATION (pathological focus cells screening) 
is performed with the following methods:  
- pathological focus smear is obtained by using gauze swab, spatula 
or other tool; 
- pathological focus reflection is obtained by using a sterile glass or 
sterile clerical gum; 
- retype from obtained smear or reflection; 
- aspiration method - sample is obtained by puncture (5.0 or 10.0 ml 
of  empty sterile syringes and needle); 
- exfoliative method - sample is obtained during cavity puncture to 
take fluid or during caviry lavage (rinse water). 
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For cytology punctates the material sample is taken with dry sterile 
syringe having tight piston friction and dry needle. After pricking the needle 
into the pathological focus several suction movements are performed, then the 
needle content is pushed by the piston onto 2-3 dry fatless slide plates and 
sliding another plate piece turned into a thin smear. If the material sample is 
obtained in the form of fluid (serous, hemohrahichnoyi and other), then 
immediately after taking it from the patient you should add to it a liquid 
solution of sodium citrate in the rate of 1 ml to 10 ml of liquid; washings, 
transudates, exudates, must be send to the examination in the full volume. 
When taken from erosive or ulcerative surface of skin, lips mucous 
membrane, mouth, tongue sample material is obtained as a result of stroke, 
smears, scrape. Before malignancy suspicious surface examination  carefully 
remove dry crusts or pus, necrotic plaque, mucus for having better access to 
the pathological focus.  
In all cases the material sample is taken for cytology by doctor who 
examined or performed surgical operation to the patient. In the referral to 
cytology to smears (tubes, bottles) you must write the name and number of 
patient histories or outpatient cards, department, institution, office, where 
patient is examined or operated. Be sure to specify from which area the 
material is taken (body anatomical area), which way (print, punctate, 
washings, etc.), what macroscopic appearance it has.  
Clinical diagnosis and performed treatment should be specified. 
Material samples for cytological examination should be delivered 
immediately after receiving it from the patient.  
Conducted the patient examination department is taken responsibility 
for material samples delivery. Atypical cells presence in the material samples 
is not a reliable basis for malignant tumors diagnosis, thus may be several 
cytological examinations. Proper cytology provides the reliability of diagnosis 
in 78-90% of cases.  
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Excepet these methods the following methods are used for the 
diagnosis: stomatoscopy, radiation methods, radioisotope methods, inductive 
methods, wave (ultrasound) and other methods as necessary.  
Thus, there is a wide range of different methods for the diagnosis of 
precancerous diseases and malignant tumors. However, the percentage of 
abandoned cases among newly diagnosed cancer patients is very high, what 
also caused high mortality rate within the first year after diagnosis.  
The main reasons for this situation are medical errors, patients late 
appeals for help, refusal from examination, hidden disease course, about 
which 60 years ago wrote A.V.Melnikov. During this passed time period the 
situation had improved. The main reason for this is to be considered a lack of 
oncologic alarm.  
 
 
The term "Oncological alarm" was introduced by A.Sh.Stavytskyy in 
1948 and included three main components: 
- suspicion of cancer; 
- careful case history; 
- compulsory examination methods usage. 
 
Later B.E.Peterson had proposed to consider the cancer alarm the 
following:   
1. Malignant tumors symptoms knowledge at early stages; 
2. Precancer knowledge and their traetment; 
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3. Oncology care knowledge, medical institutions network and with 
urgent sending clarified or suspicious pathological process patients as 
intended; 
4. Each patient who applied to the doctor of any specialty careful 
examination to detect possible cancer; 
5. The habit to think about atypical or malignant tumor complicated 
course in severe cases diagnosis possibility.   
 
According to Yu.F.Hryhorchuk and H.P.Ruzin term "cancer alarm" 
includes the following provisions: 
- precancers clinical manifestations knowledge for their early detection; 
- precancers main initiating and predisposing development agents 
knowledge to eliminate them; 
- determined visually oral cavity and skin malignant tumors early clinical 
manifestations knowledge; 
- providing cancer care structure and system knowledge for patient 
timely direction for examination and treatment; 
- minimum required dental clinic examination knowledge when 
suspected precancerous disease; 
- deontology principles knowledge in dealing with cancer patients; 
- dental oncologic patients rehabilitation in dental clinic main provisions 
knowledge, depending on clinical group. 
 
The main rule for doctors during the patients examination should be a 
full patient survey. This tactic can be explained by the following points: 
- local lesion may be a reflection (distant metastases) of tumors that 
initially localized in a completely different place; 
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- multiple primary tumors (bazaliomy, melanoma) simultaneous 
occurrence is possible; 
- satellite evident pathology can be detected during a full examination 
of the patient that may affect the amount of additional examination, 
establishing the exact diagnosis and treatment nature.  
 
After the physical examination, the doctor should decide what 
additional diagnostic methods should be applied in this case and should 
perform a full scope of examination. 
All patients in whom during periodic screenings processes that were 
suspected of belonging to precancerous diseases or malignant tumors were 
revealed, are subject to mandatory further thorough examination in outpatient 
health care facilities. In the event of necessity, the examination should be 
performed in a hospital or special general medical establishment. 
Enhance examination of persons with suspected malignancy should 
be completed in preventive and treatment institutions within 7 days. 
Examination results data are entered in the patient's medical card and records 
keeping in preventive examinations form to control the patient arrival for 
enhance examination. 
 
Organized (decreed) population in cities preventive examinations are 
performed: 
1. within industrial enterprises – by means of medical units (MU) 
resources; 
2. within enterprises and organizations that do not have their own MU, 
by means of preventive and treatment facilities to which they are attached.  
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3. unorganized population (pensioners, housewives and others) 
preventing examinations performing relies on regional clinics. 
 
Employed and unemployed population in rural areas preventive 
examinationsare made in Rural District Hospital (RDH) or rural medical 
stations, and enhanced examinations are performed by Central District 
Hospital (CDH). 
In some areas where the population due to the specifics of production 
location or remoteness of settlements removed from schools of general 
hospital network, preventive examinations are carried out by expeditionary or 
brigade methods are used.  
For all detected during preventive examinations patients with malignant 
neoplasms discovered the disease doctor must complete notification of newly 
diagnosed cancer (form number 90/u, approved by order of the Ministry of 
Health of Ukraine № 1030 dtd. October 4, 1980) and in three days forward it 
to Cancer institution in the patient place of residence. Patients precancerous 
and tumor diseases are registered in clinical records by relevant specialists, 
for each patient a control card is filled in, form №30 (clinical patients 
registration form). For each patient with newly diagnosed malignant tumor in 
stage IV of the disease, while the visual localization of tumors - in stage III 
(all localization in maxillofacial area) the "Protocol in case of detection in a 
patient the neglected form of malignant tumors" (form number 027-2/u) is 
composed. 
 
All taken under medical supervision patients should be allocated to 
following clinical groups: 
1. group Ia – suspicious for malignancy diseases patients; 
2. group Ib – precancerous diseases patients; 
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3. group II – special complex treatment subjected malignant tumors 
patients; 
4. group IIa – radical treatment subjected malignant tumors patients; 
5. group III – practically healthy individuals after malignant tumors 
radical treatment; 
6. group IV – palliative or symptomatic treated malignant tumors 
common forms patients. 
 
Ia clinical group includes patients with unclear clinical picture, having 
the presence of suspected malignancies disease. When the final diagnosisis 
confirmed Ia group patients is striked off the clinical records or transferred to 
other clinical groups. Ia clinical group patients enhanced examination should 
be organized no later than 7 days after taking on the clinical records. Patient 
may stay in Ia clinical group no longer than 10 days.  
Ib clinical group includes patients with precancerous diseases. 
II clinical group includes patients with malignant tumors, which are 
due to the use of modern treatment regimens can be completely cured from 
malignant tumors, and patients with achieved prolonged remission. 
IIa subgroup is dedicated as part of II clinical group - patients 
subjected to radical treatment. By radical treatment is understood the tumor 
treatment modern methods usage aimed to complete patient cure from tumor. 
 III clinical group - a group of healthy individuals include patients who 
received radical treatment (surgery, radiation, combined or complex 
treatment), with no recurrence and metastasis. These individuals are the object 
of observation and rehabilitation. Controlling examinations are performed 
within first year after radical treatment on a quarterly basis; within the second 
year of controlling examinations are performed twice a year; within the third 
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and subsequent years – controlling examinations should be carried out once a 
year. Individuals of this clinical group, in the case of recurrences are 
transferred to II (IIa) group for specialized treatment (surgery, radiation, etc.). 
or in IV group if special treatment is not required due to the prevalence 
process. 
IV clinical group – progressive form of malignant tumors - include 
patients special treatment for where is not possible. These patients are mainly 
receiving symptomatic and palliative treatment. This heavy contingent of 
patients requires special attention from the medical staff. For these patients is 
required prompt analgesic therapy and elimination of vital dangerous 
complications. 
 
Malignant tumors treatment can be successful only when it is 
performed at early stages of the disease and even better if you begin treatment 
at precancerous changes. Head and neck precancerous patients can seek 
treatment to dentists, ENT specialists, surgeons, dermatologists and others. 
Therefore, these specialists should be familiar with head and neck 
precancerous diseases clinical signs, malignancy signs  and cancer early signs 
in their respective areas.   
One of the most important measures in solving anticancer control 
compliance problem is systematic population comprehensive preventive 
examinations performing, as well as general outpatient care organization, 
during which any patient's examination performed by a doctor would be both 
preventive examinations aimed to detect the most common cancer locations 
and precancerous diseases.  
All precancerous diseases patients  should be under respective 
specialties doctors medical observation. High incidence malignancy 
precancerous patients are subjected to systematic monitoring and treatment in 
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oncologists (clinical group 1B). Within precancerous diseases surgical treatment 
removed tissue histological examination is compulsory. After performed 
precancerous diseases radical treatment the patients should be under active medical 
observation in a 6 - 12 months. Patients received therapeutic treatment medication, 
should be under active medical observation in a 3-6-9-12 months, within the second 
year – in a 6-12 months, if recurrence or continuation of the disease is not detected, 
the patient is transferred to entire population annual clinical examination system 
where they are included to the malignancies increased disease risk group. If during 
the process of obzervation the patient required surgical treatment, it is carried out in a 
required specialist.  
 
After performed treatment the patient should be under active medical 
observation in a 6 and 12 months if not detected recurrence or continuation of the 
disease, the patient is transferred to entire population annual clinical examination 
system where they are included to the malignancies increased disease risk group. 
Refused treatment patients should be under active medical observation every 2-3 
months. 
According to acting Ministry of Health of the USSR Order of the №192 
dtd. 07.04.1986 patients with malignancies and precanser disease high-risk 
groups formation is carried out by specialists involved in population annual 
clinical examination performing. 
Oncologist provides methodological assistance during these groups 
formation, controls registration, examination timeliness and completeness, an 
clinical supervision and recreational activities effectiveness annual analysis 
performs together with other specialists.  
During population annual clinical examination performing or when the 
patient is sicking for medical care, family doctor, dentist and other specialties 
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doctors taking into consideration the list of risk factors include examined patient 
into increased risk group. The related record is made in patient’s outpatient card. 
Persons included in the precancer diseases high risk patients group 
clinical supervision is carried out in residence territorial medical facility at the 
or in the clinic at the place of work. Dispensary observation control card (form 
№030-U) is created for each detected patient. 
Above mentioned patient population annual clinical supervision the 
necessary amount of examinations are carried out required for the component to 
oncological clinical examination. 
Within the next dispensary patients examination departmental guidelines 
listed diagnostic procedures are applied. In addition, precancer tumors patients 
are enrolled in annual clinical examination in the amount provided for the entire 
population. 
Patients treated from precancer tumor deseases should be enrolled into 
specialist control examination in a 6-12 months, afterwards they can be 
transferred to entire population annual clinical examination system where they are 
included to the malignancies increased disease risk group. 
 
Main risk factors list: 
1. Age. Male and female, 45 and older – all localizations. 
2. Bad health habits: 
- alcohol ingestion – all localizations; 
- smoking – all localizations; 
- excessively hot and spicy foods - oral mucosa, tongue;  
- local drugs (weed chewing, and etc. ) – oral mucosa, tongue. 
3. Prolonged industrial hazards (10 years and more): 
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- Outdoors working in the field of agriculture, construction, marine 
transport - lip skin; 
- Lips red border frequent burns during the metallurgical, chemical and 
glass blowing business - lip, skin, oral mucosa, tongue; 
- Automobile transport workers; workers employed in oil production 
and processing, employed in nickel and chrome plating processes, in the wood 
industry - malignant tumors of the nose, sinuses, lips, oral mucosa, tongue; 
- X-ray and radiation, chemical carcinogens performance in industrial 
environment (oil, nitropaint) influence on skin - skin malignant tumors, lips. 
4. Internal causes: 
- family (blood) relatives malignant neoplasms presence – all 
localizations; 
- melanoma presence in relatives – all localizations. 
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MAXILLOFACIAL PRECANCEROUS CONDITIONS  
PRECANCER CONCEPT  
 
 
Precancers - pathological conditions, preceding within the long period the 
tumors appearance, but not always turn to them and is a stage of carcinogenesis. The 
term ―precancer‖ (praecancer) was proposed in 1986 at the International Congress of 
Dermatologists in London by M.V.Dyubreyl. He raised the question of keratosis, a 
condition preceding the occurrence of malignant skin tumors. Since the term 
"precancers" is widely used in clinical medicine, but it should be noted that long 
before, cases of cancer at the site of various pathological conditions were known. 
Nevertheless, there is still no consensus on the importance preceding pathological 
processes in the development of malignant tumors. Some experts believe that the 
term "precancer" should encourage and not to consider it obligatory phase in the 
development of tumors. Other authors believe that every cancer has its own 
precancer, but not each precancer always turns into cancer. 
It is experimentally and clinically proved that certain pathological processes 
precede tumors development. 
A.V. Melnikov, a leading Ukrainian onkomorfologist, gives the 
following a definition of precancer: precancerous is local (hereditary, born or 
acquaired) benign skin epithelial disease, mucous membrane or parenchymal 
organ, which, located in the typical places, subjected to constant irritation 
(nonspecific) and being neglected, with stratification endogenous causes 
quantity, becomes malignant tumor.  
A.V.Melnykov conventionally identified four stages precancer to 
cancer transformation: 
a)   hyperplasia and tissue restructuring; 
b)   lesion hyperplasia; 
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c)   benign tumor formation; 
d) benign tumor to malignant transformation with specific infiltrative and 
destructive growth. 
 
L.M.Shabad identifies 4 stages in cancer development: 
1. Morphologically and functionally modified uneven diffuse hyperplasia. 
2. Lesion growths on diffuse hyperplasia background from multycentral 
anlages; immaturity signs, atypia. 
3. Focal proliferates, merge to form a unit separated from the surrounding 
tissue (benign tumor). 
4. Malignization. 
Some authors identify three histological precancerous stages: stage A - 
corresponds to the I stage of cancer according to Shabad and characterized 
only diffuse or multiple hyperplasia of epithelium; Stage B - meets the II and 
III stages according to Shabad, characterized by focal proliferation, with 
initial signs of atypia (basophilia, cytoplasmic and nuclear polymorphism); 
Stage C represents a sharp atypia and actually have the original cancer. 
Most authors consider directly precancerous stages 2 and 3, ie, focal 
proliferates and benign tumors. They propose to distinguish precancers from 
background diseases. 
In practice listed anove stages moves from one to another without clear 
boundaries; malignant tumor formation may arise without 3-rd stage.  
Thus, precancer is a dynamic state that can transferred into cancer due to 
constant changes in the cells properties toward malignancy. Precancer to cancer 
transformation occurds not only by quantitative changes (time, weight) as a result of 
biological changes in cells, specific for malignant cells qualities accumulation in 
them.  
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Precancers missing one or more characterisitics differs them from cancer. 
precancers lesion cells feature is great sensitivity to factors that cause cell 
reproduction. 
Precancers lesions dynamics varies: 
- cancer progression and development; 
- benign tumor formation; 
- regression. 
The reasons for these changes are unknown at this time, but they are directly 
dependent on immuno-biological condition of the body, duration and intensity of 
oncogenic factors. 
Venkei and Shugar, comparing their clinical classification with 
histological stages, concluded that most of the changes that belong to the 
group of optional precancer in a broad sense, histologically belongs to A 
precancer stage; most of the changes that belong to the optional precancer in a 
narrower sense, histologically "pushed" to B precancer stage, and finally 
changes belonging to obligate precancer, histologically correspond to 
group C. 
Especially revealing precancer value is determined in lips and mouth 
red border mucous membranes localization process. This is connected with 
patients monitoring availability and obviously the fact that most cancers arise 
from this location due to to the external carcinogenic factors. 
According to various statistics, oral and lips cancer precancerous 
changes precede from 92% of cases (L.A.Epshteyn) to 26% (V.A.Hremilov). 
Yet, most of the leading scientists (M.M Petrov, I.T. Shevchenko and others) 
believe that most maxillofacial localization cancers arising from precancerous 
lesions progression. 
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PRECANCER PROVOKING FACTORS 
 
 
Along with lip cancer features spatial distribution as one proof of 
solar radiation important role in the etiology of cancer localization 
several authors presented data that villagers whose work is associated 
with prolonged stay in the open areas, having lip cancer more often than 
the urban population. 
Several authors noted that the vast majority of patients with lip 
cancer  had prior various precancer diseases and pathological conditions 
(erythro- and leukoplakia, limited hyperkeratosis, papilloma, diffuse 
dyskeratoz and etc.). So far there is no consensus concerning which from 
a large number of lips diseases should really be recognized precancerous 
diseases.  
Climate factors, particularly insolation, sudden changes in 
temperature, significant wind speed, often lead to dry lips and cracking 
and disceratosis on basis of which lips cancer may develop. 
In various parts of the world, including Ukraine, the risk factors for 
cancer and oral cavity mucosa and pharynx vary. Most authors connect 
these tumors development with smoking and strong alcoholic beverages 
consumption. 
Published data analysis shows regional factors presence that 
influence maxillofacial area malignant tumors development and that must 
be considered during screening process planning and within clinical 
observations proces.  
These include the systematic use of alcohol combined with 
intensive tobacco smoking that increase oral cavity and pharynx cancer 
risk in 14.5 times because within combined usage alcohol and smoking 
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carcinogenic effects synergy is observed, but these factors may contribute 
to oral cavity cancer development independently.  
Some authors assume that at deterring from alcohol and smoking 
tobacco usage the mouth and throat cancer incidence in male decreased to 
76%, with contributions from smoking cessation, perhaps, would 
represent 33%, as a result of the exclusion of alcohol - 43%. 
The incidence of oral cavity and pharynx tissues squamous cell 
carcinoma in patients, who abuse alcohol and smoking, progressively 
increases with the drinking of alcohol and the number of cigarettes 
smoked. 
Tobacco role serious study in oral cavity cancer developing 
confirmed the clinical assumption that it acts as a carcinogen. 
Most studies indicated that alcohol is a risk factor for oral cavity, 
pharynx, larynx, esophagus, liver and lungs carcinoma in people abused 
him. 
It is established that alcohol can act as an etiological factor in 
reducing cellular immunity: head and neck cancer unusual for alcoholics 
with normal immune defense.  
The assumption was made that alcohol promotes tobacco 
carcinogens adsorbtion. Perhaps malnutrition in people consuming large 
quantities of alcohol, makes epithelial cells that keratinize more 
susceptible to malignant transformation.  
Malignant neoplasms high incidence of population in some 
countries is associated with regular, often begins with childhood, salted 
fish consumption. The authors believe that the causative factor may be 
present in dried and salted fish dimetylnitrozamin that is a strong 
organotropic carcinogen for laboratory animals. 
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 Oral mucosa most famous carcinogenesis example resulting in 
people nutrition imbalance is iron deficiency or Plummer-Vinson 
syndrome.  
 
Typical symptoms - cracks or sores in the corners of the mouth, 
yellowish skin tone, smooth red tongue and dysphagia. Confirmed the link 
between mucous membrane atrophy on esophageal tract top and mouth, 
pharynx and esophagus carcinoma development susceptibility.  Improving 
nutrition, through understanding the problem, resulting in lower incidence 
as Plummer-Vinson syndrome and head and neck cancers among women 
of Northern Sweden. 
Clinical studies have confirmed that under certain conditions, 
depending on the dose and duration of exposure, x-ray radiation can cause 
cancer. 
It is recognized nowerdays that one of the groups at high risk of cancer 
developing were people that being a child receiving therapeutic doses of X-
rays or radium applications on the head, neck or upper chest on various 
benign processes (enlarged thymus, enlarged tonsils or adenoids, mastoiditis, 
sinusitis, keloids, dermatomycosis heads, acne, etc.). In this part of population 
statistically noted a significant increase in thyroid cancer incidence and (to a 
lesser extent) the salivary glands, and other tissues. It develops latent within 
3–35 years after initial exposure. 
Another type of head and neck iatrogenic tumors caused by 
radiation - is osteosarcoma. The researchers determined exposure possible 
role in causing malignant changes in bone among 11 patients with 
osteogenic sarcoma developed through a 6–22 years following X–ray or 
gamma therapy.  
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From bone sarcoma after radiation 17 observations, which first 
reported from clinic Meyo, in 3 cases the tumor was localized in the 
region of the head: one – the lower mandible, two – at the upper. In 
another clinic Meyo study jaws and facial bones of the skull osteogenic 
sarcomas reported 19 cases of sarcoma of the lower mandible, 14 of upper 
mandible and 11 - in the area of maxillary sinuses. 
There is no evidence that intermittent exposure during dental 
radiography has a carcinogenic effect, especially now, when applied 
exclusively high X-ray films and devices with low doses. 
 
Some people because of genetic traits are at risk of cancer. There 
are three types of genetic factors that contribute to cancer:  
1) chromosome, characterized by an imbalance in the genetic 
structure, particularly the lack or, conversely, an excess of certain genetic 
material; 
2) localized in a particular gene, when the disease is caused by 
mutations or in one of the units, as in the dominant sign, or in the first 
team, as with recession sign;  
3) polygenic, which can operate at a large number of genes (this 
includes environmental factors), and no factor or gene does not play a 
major role. 
 
In the 161 monogenic disorders type examined patients were tumor 
or pre-cancerous manifestations or complications. Excluding monogenic 
trait typical for skin, thyroid and parathyroid cancer, three other 
symptoms remains associated with head and neck malignant tumors.  
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The first of them - a syndrome basal cell nevus that appears in the 
basal cell carcinoma, medulloblastomi, jaw cysts and fibroids (ovarian 
carcinoma).  
The second - a Gardner syndrome, manifested intestinal polyps, 
osteomas, fibroma, atheroma and carcinoma of the colon, oral faterova 
pancreas, thyroid and adrenal glands. Third disorder - a cherubism, which 
is characterized by numerous giant cell tumor, can lead to situations that 
pose a threat to life, such as asphyxia. 
 
Among all the possible microbial factors real value has only viruses 
in carcinogenesis. If they really cause cancer in humans, it is associated 
with specific recipient factors, such as time of infection, immune status, 
also accompanied by other diseases, genetic predisposition and cellular 
immunity decreasing. 
Since then, when in cell cultures of Berkytt African lymphoma 
identified Epstein-Barr virus (EBV), collected evidence of significant side 
connection of the disease with Berkytt African lymphoma. In almost all 
cases are EBV antibody serum, and their average titers in patients 
compared with patients from the control group significantly increased. 
Non-tropical Berkytt tumors tisssues do not obviously contain EBV DNA. 
In several authors studies is reported a significant incidence of 
syphilis in men with oral cavity cancer, particularly lips and tongue 
cancer. But other authors do not mention syphilis in their viruses and 
other microbes as etiological factors of mouth cavity cancer analysis. 
Thus, the link between the disease and oral mucosa cancer is very 
doubtful, because in each case it can be easily argued that men with 
syphilis were certainly not young, abuse tobacco and alcohol, often have 
not good nutrition all these factors may be important in causing cancer.  
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Chronic injury from destroyed tooth sharp edges, substandard 
restorations and poorly fitting dentures is the cause of oral mucosa cancer. 
The authors specify that in 20 million US citizens who use dentures, 
mouth mucosa and alveolar jaw bone carcinoma amounts about 11%. 
Thus, lips, oral mucosa and pharynx malignant tumors dynamics 
and forecast incidence suggests its growth among population. Increased 
oral mucosa cancer risk is caused by several factors, such as nutrition, 
immunological disorders, infections caused by viruses (including herpes 
type 1-alpha), phungi Candida, presence of chronic injury from exposure 
of carious teeth or poorly fitting dentures, oral hygiene underexposed and 
others.  
Among precancer should be noted oral mucosa erythroplakia and 
leukoplakia, destructive leykokeratosis, submucosal membranes fibrosis, 
trophic ulcers and long-existing papillomas, and various inflammatory 
processes should be attributed to the background diseases and conditions.  
Thus, precancer  causes can be environment negative effects (exogenous 
factors), as well as the whole body condition disorders (endogenous factors). 
 
Exogenous factors 
1. Mechanical stimulants: coarse food, different kinds of poor quality 
prostheses, filings manufacturing defects, abnormal bite, dentitions defects, teeth 
uneven worn, bad habits (keeping in mouth pencil, pens and so on.).  
Some mechanical factors include occupational hazards (N.F.Danylevskyy, 
1966): iron ore, lead, silicate dust contributes oral mucosa hyperkeratoses of 
employees in the corresponding entrprises. Mucous membrane irritation is 
promoted by aluminum buses due to galvanic currents arrising (Penev, Todorov, 
1970). 
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2. Chemical stimulants can be devidie into two groups: household and 
occupational. Household chemical irritants include spices, highly concentrated 
solutions of alcohol, tobacco (smoking, chewing), quicklime (betel). Spicy foods 
with lots of spices, which is widespread among residents of the south where the 
high frequency leukokeratosis and oral cancer is observed.  
Tobacco has a rough irritant action to the mucous membrane of the mouth. 
While smoking the body gets about 20% tabaco smoke, which contains a number of 
products for extremely strong irritant effect: pyrydinovi foundations - the most 
harmful side of influence, hydrocyanic acid, cyanide sister compounds, fatty acids, 
phenol and tar sediment. In addition, tobacco smoke, except polycyclic hydrogens 
contains 3 - 4 bensperen and arsenic. Increased tobacco products usage leads to 
increasing patients quantity with leukoplakia and oral cancer.  
One of the annoying points of smoking is the heat factor. Keratosis often 
occurs in those who puff at pipe, smoke up cigarette to the end so that the lips are 
being burned. 
 
Operational stimulants: alkalis, acids in the form of vapors, aerosols and 
other chemicals depending on the concentration and action duration may lead to 
acute or chronic chemical injury. 
The temperature stimulants: hot food, a cigarette burning lips, hot air during 
working at some enterprises. With prolonged exposure contributes to precancerous 
diseases development. 
Meteorological factors - is a environment negative agents complex that affect 
skin tissues of the face and lips. This includes the effect of sunlight, dust, wind, 
aerosols, salt water at low temperatures and high humidity. 
Biological factors: yeasts, pale spirochete, Chopsticks Koch contributing the 
tongue, mouth mucous membrane keratinization emergence, causing temporary 
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infringement keratinization in some areas of the oral mucosa and increases tendency 
to malignancy. 
 
Endogenous factors 
Anatomical and physiological features: increased keratinization oral mucosa 
tendency due to its origin from the ectoderm. The tendency to keratinization 
increases with age due to cells dehydration. Hormonal changes (especially in 
women) influence the keratinization process. Some diseases of different etiologies 
(chronic anemia, diabetes, etc.) disrupt the keratinization processes. 
Listed above factors both in isolation and together are constant companions 
of human life and render permanent effect on oral mucosa keratinization processes: 
- stress conditions: acute psychic trauma value in the event of dyskeratosis 
appearing (eg. lichen planus); 
- gastrointestinal tract diseases: within chronic gastritis, enteritis, colitis 
arising para- or hyperkeratoses states; 
- febrile states; 
- diffetent ethialogy xerostomias;  
- Lupus erythematosus, psoriasis, ichthyosis. 
42 
 
PRECANCER CLASSIFICATION 
 
 
Recently, a broad implementation in practice acquired precanser -
classification proposed by Hungarian authors - Venkei and Shugar, according 
to which all precancers are devided into obligate (mandatory) and optional. 
Optional precancers therefore are devided into optional precancers in the 
broadest sense and optional precancers in a narrow sense. 
T. Venkei and Ya. Shugar precancers classification 
І. Optional precancers  
1)   Optional precancer processes in the broadest sense (main diseases). 
2) Optional precancer processes in a narrow sense 
(keratopreccanserosis).  
ІІ. Obligate precancerous conditions or intradermal cancers. 
 
Precancerous conditions in the broad sense are characterized by the fact 
that the probability of their malignancy is below 10% of cases. These include 
senile skin atrophy; chronic ray, radiation dermatitis; dermatitis caused by the 
action of tar, arsenic, scars, chronic inflammation, including lupus, benign 
tumors and others. 
To optional precancers in the narrow sense belongs so called 
keratoprekarcenosis (senile keratosis, keratoakantoma, cutaneous horn, sores). 
Probability of malignancy at 20-30% of cases. 
To obligate skin precancers belong xeroderma pigmentosum, Bowen's 
disease, eritroplasia Keira, Paget's disease.  
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Similar principles in the distribution of lip and oral mucosa precancers 
underlying the classification established by A.L.Mashkilleyson (1970), which 
is followed both by dentists and oncologists. 
There are the following oral mucosa and lips red border precancers 
forms. 
 
A.L.Mashkilleyson precancers classification  
І. Obligate precancers: 
1) Bowen's disease and Kejer’s erythroplasia;  
2) warty or nodular lips red border precancer; 
3) abrasive precancerosis cheilitis Manganotti; 
4) lips red border limited precancerous hyperkeratosis. 
ІІ. Optional precancers with high potential malignancy: 
1)  erosive and verrucous leukoplakia; 
2)  papilloma and papillomatosis of palate; 
3)  cutaneous horn; 
4) keratokantoma. 
ІІІ. Optional precancers with less potential malignancy: 
1)  flap leukokeratosis; 
2)  oral mucosa chronic ulceration; 
3)  lips red border lupus erythematosus and red flap leave 
hiperkeratotical and erosive forms; 
4)  chronic lips cracks; 
5)  postirradiation cheilitis and stomatitis; 
6)  meteorological and actinic cheilitis. 
 
Obligate precancers - processes which are with the greatest frequency 
transformed into malignant tumors in a relatively short time. Optional 
precancers are less likely to turn into cancer at a long exposure. 
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Thus, all oral mucosa and lips red border precancerous changes are 
divided into three groups: the obligate precancerous conditions, facultative 
precancerous conditions with greater potential malignancy, characterized by 
transformation into cancer in 15-30% of cases, and precancerous conditions 
with less potential malignancy in which the malignancy occurs not more than 
6-10% of patients. In regard to histological first and second groups of diseases 
belong to the focal proliferates or so-called benign tumors (as per L.A.Shabad 
terminology), while the diseases classified in the third group, presented as 
diffuse, pathologic uneven hyperplasia. In the first group included diseases, 
histological structure of which meets the condition referred to as cancer in 
situ, so-called "offset" cancer that under international histological precancers 
classification refers to precancerous disease (Bowen's disease and Kejer’s 
erythroplasia). 
Comparing A.L. Mashkilleyson classification to Venkei and Shugar 
classification, it is noted that three groups precancerous lesions according to  
Mashkilleyson almost entirely correspond to three pathomorphological phases 
A, B and C. For example, a disease included in the first group corresponds 
histology characteristic of phase A; diseases of the second group - Phase V; 
diseases of the third group corresponds to stage B-C or C. 
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OBLIGATE PRECANCERS 
 
 
Bowen's disease was first described in 1912. The etiology and 
pathogenesis is unknown.  
The clinical picture is diverse; often localized in oral mucosa (palatine 
arch, tongue root, soft palate) posterior part, seldom in retromolar and anterior 
arears, on lips red boder. Affected area has irregularly shape. May show 
spotty-nodular lesions that gradually increase in size may have torulose 
surface and papillary proliferation. Prolonged existence light atrophy is observed, 
affected areas sinks down slightly, it may be erosioned, affected areas may merge, 
forming polycyclic contours plaques, plaque size from 0.1 to 1.0 cm. The surface 
area is hyperaemic, smooth or velvety with small papillary growths, slight 
desquamation and itching are possible. 
 
Fig 1.  Bowen’s disease 
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To differentiate is necessary from leukoplakia, lichen ruber planus, syphilis. 
Diagnosticate is only on histological examination results. 
According to clinical manifestations Bowen’s disease four forms are:  
1) papules and furfuraceous;  
2) papules and crusted;             
3) atrophic;  
4) weeping.  
 Histologically, there are giant cells in stratum spinosu with cores 
agglutination as lumps. Individual cells keratisation in malpighian layer, infiltrate 
composed of lymphocytes and plasma cells in stroma may be observed. 
Treatment. Electrosurgical wide lesions removal or cryogenic destruction. If 
surgical treatment is not possible awailable areas close-focus roentgenotherapy is 
applied. If invasive growth is detected, combined treatment method is used. 
Keyr’s erythroplasia was described in 1921. Histological picture corresponds 
to Bowen's disease (embedded in the concept "carcinoma in situ"), therefore 
Bowen's disease is being interpreted by some authors as a further stage of Keyr’s 
erythroplasia development. Other researchers do not see the need to separate 
Bowen's disease and Keyr’s erythroplasia. 
The disease starts with strictly limited bright red lesions with hardly 
noticeable thickening at the base appearing on lips, cheeks mucous membranes. 
Lesions are slightly increased over the mucosa surface. Lesions surface is smooth, 
hyperemic, some velvety. Gradually on lesion surface ulcers is appeared and disease 
becomes a cancer, may metastases in lymph nodes. This disease is characterized by 
slow motion. Treatment is only radical surgical; radiation therapy is less than 
effective, conservative methods - quite ineffective. 
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Abrasive precancerous Manhanotti’s cheilitis - refers to 
obligate lips precancers.  Among  numerous cheilitis groups Manhanotti 
in 1933 highlight one form the feature of which is very frequent  
transformation in cancer.  This form was often described by many 
oncologists like "destructive disceratosis." Cheilitis Manhanotti 
clinical manifestation differs with some varriety. The disease affects only the 
lower lip, manifesting itself in the form of one or more erosions oval or 
irregular in shape, size 0.5-1.0 cm, often with a smooth, polished surface 
having intense red color. In some patients erosion surface is partially covered 
with a thin transparent epithelium. Quite often crust (bloody or serous), which 
held quite firmly on the surface occur on erosion surface.  
 
Fig.2.  Abrasive precancerous Manhanotti ’s cheilitis 
 
Crusts removal causing minor bleeding, while erosive surface without 
crusts minor trauma does not cause bleeding. Erosion epithelization is often 
abserved and then recidive. Erosion is often located on the side of the lip, 
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sometimes - in the center. In some cases, erosion is placed on a slightly 
infiltrated and hyperemic basis, and the inflammatory response is observed 
upto 1.0-1.5 cm beyond erosion boundaries. Malignization is possible in 
within the period of several months to several years - with the formation of 
squamous cell carcinoma. Signs of malignancy: loss trends to 
epithelialization, proliferation on the background of erosion formations 
similar to granulation, increased as a roller edges of erosion, bleeding from 
erosion, compaction at the base of erosion, the emergence of a significant 
keratinization directly around erosion. Finally, possible malignant 
transformation process question can be resolved by morphological 
examination. It should be noted that sometimes, even in the absence of these 
malignancy clinical signs, histological examination can reveal a picture of 
spinocellulare (squamous cell) cancer. 
 
 
Fig. 3. Abrasive precancerous Manhanotti ’s cheilitis 
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Cheilitis Manhanotti differential diagnosis should be made with 
pemphigus, herpes, thrush, lichen planus, lupus erythematosus, erosive 
leukoplakia, eczema of the lips, ulcerative form lips cancer. 
Abrasive precancerous cheilitis Manhanotti treatment involves the use 
of drugs that stimulate epithelization erosion - retinol, thiamine chloride, 
riboflavin, niacin. Treatment should begin after irritating factors removal, oral 
cavity sanation, gastrointestinal tract pathology treatment. If the process is not 
amenable to conservative treatment, or when there are signs of malignancy, it 
should be applied surgery - removal of the lesion within healthy tissue layer 
with mandatory histological examination by layers. Clinical monitoring of 
such patients is carried out both dentists and oncologists (this applies to all 
patients with obligate precancers). 
 
 
Fig.4 Abrasive precancerous Manhanotti ’s cheilitis 
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Cheilitis Manhanotti differential diagnosis should be made with 
pemphigus, herpes, thrush, lichen planus, lupus erythematosus, erosive 
leukoplakia, eczema of the lips, ulcerative form lips cancer. 
Abrasive precancerous cheilitis Manhanotti treatment involves the use 
of drugs that stimulate epithelization erosion - retinol, thiamine chloride, 
riboflavin, niacin. Treatment should begin after irritating factors removal, oral 
cavity sanation, gastrointestinal tract pathology treatment. If the process is not 
amenable to conservative treatment, or when there are signs of malignancy, it 
should be applied surgery - removal of the lesion within healthy tissue layer 
with mandatory histological examination by layers. Clinical monitoring of 
such patients is carried out both dentists and oncologists (this applies to all 
patients with obligate precancers). 
 
Nodular or warty  (verrucous carcinoma) lips red border 
precancer. The disease was described by A.L. Mashkilleyson in 1970. In 
comparison with Manhanotti cheilitis is more common in younger people. 
Typically, the lesion is localized a side from the center of lips, mostly in 
lower lip, within the red border without spreading to the skin or in the Klein 
zone.  
Clinically the lesion is similar to papilloma or wart, has clear limits. 
Element size from 4 mm to 1.0 cm, semispheric form above the level of the 
surrounding red border of 3-5 mm, has a dense texture. The color changes 
from red border normal color to stagnant red. In most patients usually nodule 
surface is covered with a small number of scales that cling to the surface 
without stripping while rubbing. In such cases, the surface becomes grayish-
red. Nodule palpation is usually painless. Most often this element is situated 
on not changed red boder, sometimes – having slight inflammation 
background. 
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Fig 5. Verrucous carcinoma 
 
Verrucous carcinoma course is pretty fast. Malignization process may 
happen after 1-2 months after the onset of disease, although in some patients 
this process continues for 1-3 years. 
Verrucous carcinoma differential diagnosis should be done with 
ordinary warts, papilloma, keratoacanthoma, pyogenic granuloma. 
 To verrucous carcinoma malignancy signs must be referred growth 
acceleration, surface nodule enhance keratinization processes. Great 
importance should be given to the induration forming at element base and 
pain arrising. But we should point out the relativity of these signs, which may 
sometimes be absent during malignancy. 
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Fig. 6. Warty  lips red border precancer 
 
Lips red border verrucous carcinoma treatment consists of complete 
surgical removal of lesion area with the following optional morphological 
examination. Lesion excision is best to be performed by electric knife within 
the healthy tissue limits. Electrocoagulation and cryodestruction in its purest 
form should never be done, because they deprive the possibility of 
morphological verification process performing. 
Clinical monitoring is carried out both dentist and oncologist, because 
there is a high probability of malignancy, if lesion removal within healthy 
tissue is not timely performed. 
Preventive measures. Protection from the effects of adverse weather 
factors and above all the insolation. Avoid lips red border trauma. Lips 
chronic inflammation timely treatment, systematic oral cavity sanation. 
Smoking forbidden.  
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Lips red border limited precancerous hyperkeratosis . 
Described by A.L.Mashkilleyson in 1965. Prior to that clinicians treated the 
disease as leukoplakia. But from leukoplakia limited precancerous 
hyperkeratosis differs not only clinically, but in fact by its progress process 
because it has much more potential malignancy compared with leukoplakia 
and belongs to obligate precancers. Unlike other precancers young and middle 
age people mostly affected in this group. The process also localized mainly on 
the lower lip, but more often - about halfway between the center of the lips 
and mouth angle. 
 
 
Fig. 7. Red border lower lip precancerous hyperkeratosis 
 
Clinically limited precancerous hyperkeratosis is manifested in the 
form of limited areas, which often polygonal shape, with size of 0.2 to 1.5 cm. 
Most patients lesion surface does not rise above the surrounding red border, 
but often the opposite seems slightly reduced, light, surrounded by a thin 
54 
 
whitish roller. The surface area covered by such agglutination tightly-spaced 
scales grayish and brown color.  During palpation the lesion is painless, soft. 
Limited precancerous hyperkeratosis course is slower compared with 
precancer nodular form. Affected areas can exist without malignancy for 
several years, but sometimes malignancy may occur during the first year of 
the disease and even during the first months. Limited precancerous 
hyperkeratosis large quantity malignancy cases are the basis for putting this 
form to a group of obligate precancers.  
  
 
Fig. 8. Red border lower lip precancerous hyperkeratosis 
 
Limited precancerous hyperkeratosis differential diagnosis should be 
made with leukoplakia, exfoliative cheilitis, lichen and red flaps lupus 
erythematosus. During lips red border precancerous limited hyperkeratosis 
patient examination the most difficult is the question whether the malignancy 
process has already occured. With clinical signs that are at least partially help 
to address this issue, Mashkilleyson specified three ones: strengthening 
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keratinization process, formation of erosion on the surface and formation of 
the seals at the base of lesion. Therefore, the only reliable means of diagnosis 
is biopsy, which is recommended as soon as possible. 
Limited precancerous hyperkeratosis treatment is surgical removal of 
the lesion within healthy tissues limits. Better to perform elektroexcesion. 
Removed tissue samples must be histologically examined. The outcome of 
subsequent therapy depends on the results of the above histological 
examination.  
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OPTIONAL PRE-CANCEROUS DISEASES WITH GREAT 
POTENTIAL MALIGNANCY  
 
 
Leukokeratosis verrucous. Localization: cheeks, mouth floor, tongue, 
lip mucous membrane. Expressed keratinization process. It has two forms. 
Warty form - indurated, bumpy, sometimes grayish-white milky formation of 
the warty growths on the surface. Plaque form -smooth sharply restricted 
irregularly shaped plaques, towering above the surrounding mucosa milky white 
cloured, with a rough surface. 
Treatment. Lesion surgical removal. 
 
Fig. 9. Leukokeratosis verrucous 
 
Preventive measures. Refusal from smoking, oral mucosa sharp teeth edges 
chronic trauma elimination, with malocclusion poorly made dentures, eliminating 
irritating foods, alcohol. Prosthetic using homogeneous metal to prevent 
galvanization. 
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Erosive leukokeratosis. Arrises as flap or verrucous leukokeratosis 
consequency. On the background of flap or verrucous leukokeratosis lesions 
cracks or erosion occur, accompanied by pain, heartburn, etc., especially 
when taking foods. Cracks are periodically increased or epithelialized.   
 
 
Fig. 10. Erosive leukokeratosis  
 
Treatment.  Therapeutic medication that accelerate epithelization (gel 
"Solcoseryl"), with the failure - remove surgically. 
Preventive measures. Avoid insolation, lubricate lips with cream, fat,  
occasionally take vitamin A concentrate 10 drops 3 times per day within two 
months, refusal from smoking.  
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Fig. 11. Erosive and verrucous leukokeratosis   
 
Papilloma. The tumor on the shank or on a wide basis, may resemble a wart 
or cauliflower, sometimes on the surface can be villi. It is distinguished grayish-
white keratinizing and nonkeratinizing papillomas - the color does not differ from 
the color of the tissue on which it is located. Localized on the skin, lips, oral mucosa 
and tongue. 
Treatment. Surgical removal. 
Preventive measures. Avoid traumatization.  
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Fig. 12. Tongue papilloma 
Papillomatosis. Multiple papillomas proliferation on a separate part of the 
skin, lips or oral mucosa and tongue. Appeared dense knots, well shaped, congestive 
red, towering above the surrounding surface, hemispherical shape, size 0.2 - 0.4 cm.  
 
Fig. 13. Side surface toungue papillomas 
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Sometimes nodules coalesce. Their surface due to keratinization may take 
grayish-white colour. Favorite localization - hard and soft palate mucous 
membrane. 
Treatment. Surgically removal. 
 
 
Fig. 14. Oral cavity papillomatosis 
 
Preventive measures. Oral cavity sanation with rational prosthetics. Sparing 
diet. Smoking and alcohol consumption prohibition.  
Keratoakantoma.  Thick bundle round shape grayish-red, size 1 - 1,5sm in 
diameter, with sealed edges and distinctive bell-shaped hollow in the center, filled 
with horny masses freely removed.   
Teratment. Surgically removal. 
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Fig.15. Upper lip keratoakantoma 
        
 
Fig. 16. Nasal tip keratoakantoma  
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Cutaneous horn looks clearly limited lesions with 0.3 - 0.5 cm diameter at 
the base, from which conical shape formation departs with height 0.5 cm -1 
grayish color, tightly adhered to the base.   
 
Fig. 17. Cutaneous horn  
 
Fig. 18. Lower lip cutaneous horn 
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More often one lesion is developing, but may be more. Location: leather or 
red border of the lips. It affects the elderly people. 
Treatment. Surgical removal. 
 
Fig. 19. Cheek cutaneous horn 
 
Preventive measures. Lips and skin red border inflammatory processes 
timely treatment. 
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OPTIONAL PRE-CANCEROUS DISEASES WITH LESS POTENTIAL 
MALIGNANCY 
 
 
Leukoplakia plana is observed as limited nidus of keratinization, 
different shapes and sizes, not increased above the surface of the mucous 
membrane; the surface can be folded, grayish-white color, matte; sometimes, 
around the nidus, may be inflammation. The most common localization: 
mucous membrane of the cheek, retro-molar areas, at least – oral floor, 
tongue, mucous membrane of the lips. 
 
  
Fig. 20. Leukoplakia plana of buccal area 
 
Treatment is conservative, medication (sea buckthorn or wild rose oil, 
"Aekol", "Aevit"). 
Preventive measures are refusal from smoking, elimination of chronic 
trauma of the oral mucosa by sharp edges of teeth, by poorly made dentures at 
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malocclusion, elimination of irritating foods, alcohol; prosthetic by 
homogeneous metal to prevent galvanization. 
 
Fig. 21. Leukoplakia plana of lower lip 
 
 
Fig. 22. Leukoplakia plana of mucouse membrane of alveolar process. 
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Erosive-ulcerative and hyperkeratotic forms of lupus 
erythematosus and lichen ruber planus. The manifestations of lupus 
erythematosus are happened more often on exposed skin, red border of lips 
and oral mucous membranes.  
 
Fig. 23. Erosive-ulcerative forms of lichen ruber planus  
 
There are erosions with clear borders that bleed easily, are not subject 
to epithelialization, and with an infiltration of the base against hyperaemia at 
erosive-ulcerative form of lupus erythematosus. Hyperkeratosis is small. 
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Fig. 24. The lichen ruber planus (generalizating form) 
 
Treatment is synthetic antimalarial drugs with small doses of 
corticosteroids (prednisone, dexamethasone) and B vitamins, especially, 
nicotinic acid. Locally – application of ointments with corticosteroids. 
 
Fig. 25. Systemic lupus erythematosus 
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Fig. 26. Systemic lupus erythematosus 
 
Preventive measures are avoidance of excessive insolation. It is 
necessary to use ointments that contain sunscreen agents, fenilsalitsylat 10%, 
5% quinine to protect from UV rays. These ointments should be applied in the 
autumn and spring and summer regardless of the presence or absence of 
lesions of hyperaemia. 
The pathological nidus at lichen ruber planus are observed on the 
buccal mucosa in the region of the last molar on teeth joing line; on tongue; 
lip and palate are affected rare. 
The erosive form of lichen ruber planus is charactirizated by erosions 
and ulcers that are covered by fibrinous coating and bleeds after its removal. 
There are typical papular cellular-like eruptions around erosions and ulcers 
hyperemic and swollen base. The hyperkeratotic form of lichen ruber planus 
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is characterisated by stagnant hyperkeratosis that increase the level of red 
border of the lips as leukoplakia-like plaques. 
 
 
Fig. 27. Systemic lupus erythematosus 
 
Treatment is acceptance of prednisolone and delagil inside. If there are 
contraindications to the appointment of corticosteroid drugs inside, it can be 
used hydrocortisone injections in the mucous membrane under nidus, 
ointments "Holisal", "Solcoseryl" and ―Prednizolon‖. In case of failure of 
treatment it is necessary to do surgical removal of the nidus. 
Preventive measures are timely treatment of lichen ruber planus, 
avoidance of injury, excessive insolation, refusal from smoking, rational 
prosthesis. 
Cheilitis after irradiation. The clinical symptoms are: hyperaemia of 
lips dryness, cracks, erosion, atrophy. On the surface may be warty or 
hyperkeratosis growths of the epithelium. 
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Fig. 28. The cheilitis after irradiation  
 
Treatment is using of ointments with corticosteroid drugs methyluracil, 
sometimes quinoline series drugs are prescribed inside. 
Preventive measures are avoidance of excessive UV-insolation. 
Stomatitis after irradiation. The humid mucositis sometimes with 
erosive-ulcerative character is happened on the oral mucosa and the tongue. 
Epithelial cover in the area of irradiation may be exposed by keratinization. 
Treatment is applications of rose hips or buckthorn oil, and other fatty 
substances. Rinse by antiseptic solutions, including metacil or chlorophyllipt 
solution. 
Preventive measures are avoidance of excessive UV-insolation. 
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Fig. 29. The stomatis after irradiation  
 
Actinic and weather cheilitis is damaged of red border of the lips, 
which occurs during prolonged exposure to sunlight. Clinically distinguish 
two forms: exudative, which is characterized by edema and hyperemia, the 
emergence of papulas on this background, erosions, crusts, scales, cracks; and 
dry form. This form is characterizated by bright red border that is covered 
with grayish-white scales that after removal happend again. Then the red 
border becomes dry, rough, easily vulnerable; patients complane on feeling of 
burning, pruritus, pain. This disease is characterized by relapses in the spring 
and summer. 
Treatment istherapeutic with use of drugs: protective creams, rosehip 
and sea buckthorn oil, ―Solcoseryl‖. 
Preventive measures are protection of the lips from excessive action of 
sunlight, use sunscreen ointments. 
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PRECANCEROUS DISEASES OF FACE SKIN 
 
 
Obligate precancerous skin diseases 
Xeroderma pigmentosum. The mode of inheritance is autosomal-
recessive. In the event of illness there is important role of blood kinship 
parents and innate sensitivity to sunlight. The skin of patients is extremely 
sensitive to sunlight and its changes lead to malignancy. 
 
Fig. 30. Xeroderma pigmentosum  
 
Clinical picture. 2-3-year-olds children get redness, peeling, dryness of 
open areas of skin (face, neck, hands) in the spring and summer. There are 
swollen erythematouse areas without clearly separations after exposure to the 
sun. It is formed the pigmentation as lentigo and freckles after the resolution 
of erythema. In superficial pigmentation appear white atrophy, 
telangiectasias, keratoses. Number of pigmentation increases, the skin 
becomes colorful, and areas of atrophy can cause atresia of mouth, ectropion. 
In addition, skin lesions are accompanied by conjunctivitis and photophobia. 
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Atrophic changes lead to thinning of the ears and nose, loss of eyelashes. The 
warty growths develop from keratosis that eventually transformed into 
epithelioma, and sometimes, sarcoma and melanoma. Neoplasms can 
metastasize to internal organs. In addition, bone dystrophy, microcephaly, 
retarded physical and mental development are noted at these patients. Most 
patients die before the age of 15. 
Treatment.  Bracing therapy. 
Preventive measures. Maximum restraint from solar and ultraviolet 
insolation. 
Bowen's disease. It is the precancerous dermatosis that is inherently 
intraepidermal cancer. Sometimes it is localized on the face. It is 
characterizated by uneven growthing of on the periphery of the lesion, its 
diversity because of the erosive areas, superficial atrophy, hyperkeratosis and 
foci of increased peripheral rollers. 
 
Fig. 31. Bowen's disease 
74 
 
The central area is ingrained, rough, slightly warty, covered with scales 
and crusts, under which there is uneven papilomatouse surface with erosions. 
Ulcer can rarely decay. Announced border gets more intense color. If the 
dense tumor within pockets is formed, with disposision to ulceration, Bowen's 
disease becomes into squamous cell carcinoma. 
Treatment. Wide excision, diathermocoagulation, cryosurgery, laser 
and X-ray therapy. Simultaneously etretynat is administered at a dose of 1 
mg/kg of body weight. 
Preventive measures. Avoid trauma. 
Barrett-Yadasson’s epithelioma. It affects the elderly people.It is 
intradermal tumor. Usually it gets one nidus, plaque is round or oval, pink or 
broun color, smooth or warty, shiny or covered with scales that exfoliate. If 
there are ulcers thay usually cancerate. It should be differentiated from 
psoriasis, nevus, papilloma. 
Treatment. Surgical removal. 
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OPTIONAL PRECANCEROUS SKIN DISEASES 
  
 
Keratoma (senile atrophy). The skin becomes dry, thin, wrinkled. It 
appears yellowish-brown spots that rise, covered with a thick crust that is 
difficult to remove. At prolonged traumatization the senile keratoma can get 
the malignization. 
  
Fig. 32. Seborehating teratoma 
 
Treatment. Surgical treatment, electroinsision, laser removal, short-
focal radiotherapy 
Actinic keratosis – is a type of seborrheic (senile) keratosis on 
dystrophic skin of face (sailors and people who working for a long time on the 
open air). 
Treatment. Electrocoagulation or cryosurgery of keratosis niduls. 
Vitamine A. 
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Preventive measures. To ezclude the adverse weather action. 
Late radiation ulcers. This is the skin ulcer that heals hardly, with 
areas of atrophy and telangiectasias around the site of radiation action (can be 
many years after it). 
Treatment is unirritating local anti-inflammatory and epithelizating 
treatment, vitaminotherapy. Surgical removal in case of indacation. 
Preventive measures. Eliminate re-radiation effects and UV insolation. 
Tryhoepithelioma. It is a benign tumor of the skin appendages. This is 
usually hereditary congenital disease. This tumor arises on the face, 
sometimes on the scalp in the form of multiple, dense, tumor-like nodules, the 
size of 0.3-0.5 cm, round shape, color is from light pink to yellowish, with 
venouse lake on the surface. Tryhoepithelioma exists for a long time, grows 
slowly and can be transformed into basalioma. 
 
 
Fig. 33. Tryhoepithelioma 
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Treatment is surgical: wide excision of rash elements, 
electrocoagulation, cryosurgery, laser removal, dermabrasion. 
Preventive measures. Avoid traumatic injuries. 
Skin horn. It is a benign epithelial tumor, which mainly located on the 
face, scalp. Usually it developes on plase of senile keratoma at the elderly 
people, but it may occur in areas of scars, papilloma, focal tuberculous lupus, 
after chronic X-ray lesions of skin. Tumor is cone formation from horny 
masses of yellowish-brown or dark colors, length is several centimeters. The 
base of tumors is dense, the surface is covered by longitudinal and transverse 
grooves. Inflammation signs are abcent. Often this tumos can transform into 
skin cancer in old age. 
Treatment. The best result is obtained by the use of liquid nitrogen with 
curettage; application of 70% glycolic acid for 3-5 minutes should prevent the 
curettage. It is possible to use diathermocoagulation, laser therapy. 
Preventive measures. Timely treatment of keratomas, papillomas and 
others diseases that precede the appearance of skin horn. 
Papilloma. It is the most bening tumor of skin. It developed from the 
surface epithelium.  
Papillomas are diagnosed as solitary (single) and multiple 
(papillomatosis). Approximately 20% of patients papilloma can become 
malignant. Papillomas localized in different areas of the face.  
Their clinical symptoms varied: a thin or thick stalk, round or oval, 
smooth or wrinkled surface with papillary excrescences of keratinizing or 
non-keratinizing epithelium of various size (0.5-2.0 cm). The presence of 
multiple papillomas is determined as papillomatosis of skin. Papillomas with 
keratinizing changes often becom/e malignant. 
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Fig. 34. Papilomas of upper eyelid 
 
 
Fig. 35. Papilomas of upper eyelid 
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Naevus. It is pigment formation on the skin of neuroectodermal origin, 
which includes nevus cells with melanin. 
The most complete classification of pigmented nevus is the 
classification by M.Z. Segal, which is shown in the thesis ob A.S.Abdullin 
(1967), in which tumors are divided as follows. 
1. The appearance: 
a) plana; 
b) plana-lumpy; 
c) papilomatose; 
d) knotted; 
d) on the leg; 
h) warty. 
2. The size: 
a) speckled; 
b) medium; 
a) large; 
d) gigant. 
3. The color: 
a) gray-brown; 
b) brown; 
c) black; 
g) dark blue. 
4. The presence of hair: 
a) with hair-covering; 
b) without hair-covering. 
5. For the clinical course: 
a) those buried; 
b) complicated. 
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Fig. 36. Naevus  
 
А A.I. Paches (1983) has noted that the size and color of nevus is 
extremely diverse, they are not factors which determine the nature of the 
process and are unlikely to be the basis for classification. 
In practical work A.I.Paches (1983) has proposed the following clinical 
and anatomical form nevus: 
1. The plana nevus – it increases slightly above the skin surface, it is smooth, 
black or brown, sometimes with hair. 
2. Tubercular nevus – it is also with clear boundaries, but the surface is 
bumpy. often color is brown, with hair. 
3. Papilomatose nevus – its forms are multiple, there are papillary eminences, 
the color is varied, eminences often have no pigment, texture is soft, hair is 
usually abcent. 
4. Nodular nevus - node is smooth, dense, color is brown or blue, sometimes 
the nodule has a foot that looks like a mushroom, hair is abcent. 
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5. Warty nevus – the neoplasme with grooves of varying depth, often black 
color, hair is present. 
 
Warty or plana nevuses are frequently observed on the face skin. 
Papilomatose nevus is observed on the red border of lips, sometimes at 
external margin of orbit. According to the literature, boundary nevus often 
becomes malignant, at least - blue. 
Congenital pigmented nevi usually grow slowly in children, before 
puberty period growth may stop. In patients with congenital nevi rarely 
happened their malignancy. Nevi that were extrauterine period in child 
development, tend to malignant transformation. 
Treatment. Remove Nevi that are located at the sites of constant 
irritation, trauma or for cosmetic indications should be removed. 
Preventive measures. Avoid traumatic and irritating factors, excessive 
action of solar insolation. 
Limited precancerous melanosis of Dubrey. The disease mostly 
elderly and senile age. The main localization is face. Usually – the one focus 
with uneven pigmentation disorders, flaking, sometimes - erosion. 
Treatment. Complete removal of neoplasme within healthy tissues. 
Preventive measures. Avoid trauma and sunlight. 
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SECTION III 
 
APPLICABILITY OF PHOTOTHERAPY BY DEVICE «UFL-122» IN 
COMBINATION WITH GEL "SOLCOSERYL" FOR THE 
TREATMENT OF PRECANCEROUS LESIONS OF THE ORAL 
MUCOSA AND LIPS (EROSION, FISSURES, ULCERS THAT 
PROLONGED HEALING). 
 
 
The spectra of light radiation of multifunctional machine «UFL-122» 
(firm Lux-dent, Kyiv) is studied in this work. The ability to use light sources 
«UFL-122» for phototherapy with Solcoseryl (gel) of precancerous lesions of 
the oral mucosa and lips (erosion, fissures, ulcers, prolonged healing) is 
prooved. The absorption capacity of the gel Solcoseryl and its optical density 
are studied.* 
With the advent of lasers which give a strong, coherent monochromatic, 
polarized light, began the development and implementation of a variety of 
optical methods in medical practice. The good therapeutic effect can be 
obtained by quasi-monochromatic light [9]. 
Phototherapy is based on photo-biological processes. One of its variants 
is photodynamic therapy (PDT) [8]. Antimicrobial PDT is effectively used for 
the treatment of infectious inflammation of periodontal tissues [1, 5] and root 
canals, periodontal pockets, the periimplantitis, deep caries [7]. 
This seems to be an easy, safe and noninvasive system capable of 
helping the dentist to better visualize lesions, as well as its edges. Another 
point to consider is that the lesion seems to be bigger under 
chemiluminescence light. One disadvantage is that this system is expensive 
and a stick is used for each patient. Furthermore, chemiluminescence light 
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seems to be nonspecific as it does not identify the lesion etiology — whether 
inflammatory, neoplastic benign, or neoplastic malign — and this could lead 
to unnecessary biopsies 
For achievement of desired therapeutic effect during using of 
phototherapy methods it should be pick up the light of a certain wavelength 
and ensure its access to tissues that require therapeutic intervention. It is 
important to know the effective of wavelength at which maximum system 
absorbs light energy and as a result generates free radicals, which in turn 
affects the chemical reactions and biological processes. 
So the light absorption has the important role in a phototherapy. The 
positive effect will be better with more absorption of light energy, but on the 
other hand less light will penetrate to the tissues located deeper, which will 
reduce the therapeutic effect. 
 
Fig. 37. Quasilaser «UFL-122»  
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In absorption colorimetric it is exercised transmittance measurement τ (
0I
I
 ,where I - the intensity of the light that has passed through the object, 0I  - 
the intensity of the incident parallel beam) and the optical density of the medium 
D (

1
lgD ) a narrow range of wavelengths of light.  
The basis is colorimetric analysis by Bouguer - Lambert - Beer, whereby 
the intensity of the beam at the output layer of the substance is given by: 
hk
eII 
 0 , 
where h  - the thickness of the material; k  - Absorption coefficient, 
which depends on the wavelength of the incident light, the chemical nature 
and state of matter, but depends on its intensity. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 38. Leukoplakia plana of oral floor. Diagnostic by quasilaser 
«UFL-122», green color. 
 
In dental clinics the device «UFL-122» is used, the source light flux 
which has a quartz-halogen lamp Philips (13164) power 200W. System of 
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interference filters makes it possible to provide the necessary range of areas 
and absorb most other components, including ultraviolet and infrared. It 
provides optical radiation in five different spectral bands of the visible area of 
the spectrum. Analysis of the radiation spectrum shows that the maximum for 
UF filter corresponds to нм487 for G - G – nm567 , for R - nm602 . 
The intensity or flux of density at the output of the fiber may lie within 50 - 
300 mW/cm2 - for red and 100–1300 mW/cm2 - to orange light. 
 
 
Fig. 39. Erosive-ulcerative forms of lichen ruber planus. Diagnostic by 
quasilaser «UFL-122», green color. 
 
The aim of our study was to study the absorption of light by damaged 
mucosa in the treatment of precancerous lesions of the oral mucosa and lips 
(erosion, fissures, ulcers, prolonged healing) and without using 
SOLCOSERYL (gel). Rate change in the intensity of red and orange light 
with its depth of penetration into the tissue of the damaged mucosa. To prove 
86 
 
the possibility of using «UFL-122» as a light source for phototherapy 
implementation. 
 
Materials and methods. 
To determine the transmittance coefficient of mucosal tissue special 
designs were produced by standard technology. They were the slices of tissue 
taken at 1 mm, 2.5 mm, 4,5 mm levels, thickness from 4 till 40 micrometers 
placed on glass slides.   
Two types of tissue were studied that was the squamous-cell with 
keratinization (malignant) and overgrowth of dense connective tissue soft 
plasmocells infiltrates and hemorrhages without tumor (benign). The 
experiment was carried out based on the photoelectric colorimeter FEK-2, 
which makes it possible to conduct a study on the narrow spectral ranges with 
peaks that correspond to wavelengths of 400, 440, 490, 540, 590, 670, 
750 nm. A beam of light, limiting diaphragm and placed in his way without a 
substantive piece of glass cut tissue.  
Changing the sensitivity of the gauge set up the arrow on the scale. In 
light path placed the sample and fixed display gauge - transmittance τ tissue. 
Similarly it was conducted experiment with ―SOLCOSERYL‖ by placing it in 
a standard cell device. 
 
The results of research and discussion. 
Dependence of transmittance coefficient from wavelength for benign 
tissue sections at the same thickness, taken at three levels are presented in 
Fig. 1 and for malignant tissues - in Fig. 1b. Maximum absorption for all 
investigated tissues responsible wavelength ranges to 500-700 nm with a 
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maximum at 550 nm. No significant differences in the nature of absorption of 
benign and malignant tissue were found. Fig. 1 shows the dependence of a 
transmittance coefficient of wavelength for ―SOLCOSERYL‖ layer thickness 
is 2mm. Absorption of light is low and clearly not dependent on the 
wavelength. 
 
 
Fig. 40. A diagrame of dependence of transmittance versus wavelength 
for tissue with benign formaions. 
 
 
Fig. 41. A diagrame of dependence of transmittance versus wavelength 
for tissue with malignant formaions. 
Рис. 1. а. Графік залежності коефіцієнта пропускання від 
довжини хвилі для тканин із доброякісними утвореннями
60
65
70
75
80
85
90
95
100
300 400 500 600 700 800
λ, нм
τ,
 %
І рівень
ІІ рівень
ІІІ рівень
Рис. 1. б. Графік залежності коефіцієнта пропускання від 
довжини хвилі для тканин із злоякісними утвореннями
60
65
70
75
80
85
90
95
100
300 400 500 600 700 800
λ, нм
τ,
 %
І рівень
ІІ рівень
ІІІ рівень
88 
 
 
I level 
II level 
III level 
 
 
 
Fig. 42. A diagrame of dependence of transmittance versus wavelength 
for Solcoseril. 
 
Comparing the absorption specters it can be concluded that the greater 
effect is achieved when irradiated with light in the wavelength range 550 - 
650nm, which has color from yellow-green to red. 
During study of dependence of light absorption on the thickness of 
malignant and benign tissue, taken at different levels using the same filters 
colorimeter, there was no significant difference in the nature of absorption. 
Fig. 2 presents graphs showing the dependence of the optical density of the 
substance D material thickness in micrometers for wavelengths belonging to 
four spectral intervals. The figure shows that with decreasing wavelength of 
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the optical density of the medium grows faster with increasing depth of 
penetration of light. 
 
 
Fig. 43. A diagrame of dependence of absorbance mucosal tissues of 
thickness for wavelengths in four intervals 
 
 
Fig. 44. A diagrame of dependence of absorbance mucosal tissues of 
thickness for wavelengths in four intervals 
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Fig. 45. A diagrame of dependence of absorbance mucosal tissues of 
thickness for wavelengths 660-68- nm with and without Solcoseril in four 
intervals 
 
Dependencies of transmittance coefficient of mucosal tissues with the 
thickness of absorbing layer for different wavelengths are presented at Fig. 3. 
The intensity of light red is reduced by about 10 times during passage through 
tissues layer thickness of 1 mm, and the intensity of green light is reduced 10 
times at a distance 100 mkm. 
So permeable ability of light depends on the wavelength of light and it 
is the largest for light red. This makes it possible to use as a light source the 
quasi-monochromatic red light by device «UFL-122", which accounts for 
maximum radiation wavelength nm602 . 
According to averaged experimental data, plots of optical density on 
the thickness for benign and malignant tissues using and without Solcoseryl 
for the spectral range of 660 - 680nm are presented in Figure4. The graph 
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shows that the introduction of Solcoseryl is slightly reduced the absorption of 
upper layers of tissue that provides its penetration to the deeper layers. 
 
Conclusions 
So, significant differences in the nature of light absorption for benign 
and malignant tissue, taken at various levels, were not found. More light 
absorption is occurred in the wavelength range 550 – 650 nm, which has color 
from yellow-green till red. The optical density of matter for both kinds of 
tissues is linearly increased with the increasing of layer thickness. The optical 
density is faster increased at decrease of thickness of tissue with the decrease 
of wavelength. Introduction of Solcoseryl slightly reduces the light absorption 
of upper layers of tissue. Red light is more permeable. So, red and orange 
lights that are produced by «UFL-122» can be used for the implementation of 
phototherapy." 
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PROSPECTS OF OPTIMIZING OF THE DIAGNOSIS AND 
TREATMENT OF PRECANCEROUS DISEASES OF THE MUCOUS 
MEMBRANE OF THE ORAL CAVITY. TREATMENT. 
PREVENTION. 
 
 
The role of active stomatological examination of patients increases for 
early detection of precancerous diseases and prevent their malignancy that is 
based on the characteristics of clinical manifestations of late treatment of 
patients. The importance of modern diagnosis and treatment of precancer of 
the oral mucosa and lips red border are extremely increased. However, 
practical implementation of this topic is inadequate.  
Data of analysis of number of medical institutions revealed poor results 
of providing specialized aid to the numerous patients. It became apparent that 
one reason for rising incidence of malignant transformation of precancer is 
the ratio of doctors to some of its common shapes (leukoplakia plana, ulcers 
with prolonged healing) as to background diseases that are not dangerous. The 
same number of causes is long-term therapeutic (conservative) treatment that 
is not provided the criterion of radical transition. The lack of opportunities for 
stomatoscopy and other methods of additional diagnostics cause prevention of 
reasonable choice of treatment and establishment of indications for biopsy. 
According to several studies it is known that many general practitioners 
and dentists do not diagnose precancerous conditions of the oral cavity [2, 6, 
18, 58, 67] due to improper treatment or due to lack of knowledge of this 
disease. For example therapists from the UK [28] believe that dentists are 
responsible primarily for identifying oral cancer.  
Research of J.D. Krisman indicates that the US therapeutics 
stomatologist could not immediately establish the diagnosis of oral floor 
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cancer, because they confuse it with traumatic or infectious inflammatory 
lesions. 
Therapists stomatologist have a unique opportunity to identify 
malignant tumors of the oral cavity on early stages. But studies show that 
general practitioners do not hold oral examination to identify this pathology. 
J.M. Elwood has noted that 94% of patients at a late stage oral cancer were 
inspected by therapist for one year already having the disease. G.R. Lynch 
and M.N. Prout have found that only 3% of stomatologist documented that 
they had a full screening assessment of oral cancer for their patients with high 
risk of cancer development. 
It was noted that dentists get mistakes and not diagnosed in time the 
early manifestations of precancer formations and oral cancer. 
According to J.F. Shnetler stomatologists are less familiar with the 
diagnosis and early detected of precancerous lesions than general 
practitioners. B.T. Mahir has indicated that only 14% of all doctors-
stomatologits carried out intraoral examination in full.  
In previous reports J. Scotland, M.A. Pohrel have stated that dentists 
passed twice  asymptomatic cancer cases of oral cavity than reveal. F. Coffin 
has noted that dentists could not identify oral cancer in 69% of cases 
presented to them. At the same time as another study that focused on both 
general practitioners and for doctors - dentists found that 15% of patients had 
cases of incorrect diagnosis or a delayed diagnosis of oral cancer. 
Recent studies have reported that clinicians often do not know about 
the habits of their patients associated with high risk of malignant tumors of 
the oral cavity. According to research data of B.T. Mahir, 64% of dentists are 
not aware of the habit of smoking patients, and 40% did not know about 
addiction to alcohol. T.A. Dolan has observed that only 35% of US dentists 
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asked all or almost all of their patients about smoking habit. Even less than 
15% of dentists ask patients about their habit of chewing tobacco. 
Adult population of Ukraine and other countries are not sufficiently 
informed about the symptoms and signs of precancer and oral cancer. 
From the data of world literature it is knows that cytologists, who are 
studying the oral mucosa, describe a new diagnostic method to obtain tissue 
samples for histological analysis. The doctor uses a stiff brush to the oral 
mucosa under significant pressure to make the bleeding point to ensure proper 
sampling of the deeper layers of the epithelium. Further, cell samples can be 
analyzed by variety of unique diagnostic techniques such as 
cytomorphometry, DNA cytometry, immunocytochemical analysis. 
The newest computer system Oral CDx, (Brush test) allows to do the 
brush-biopsy analysis using a computer program for morphological and 
cytological analysis of tissue samples. Computerized analysis cell divides, 
based on the number of abnormal cells, which are then available to cytologist 
for further distribution and classification. 
Oral CDx test sensitivity varies from 71% till 100%, specificity is 27% 
- 94%. It has 100% coincidence with results of usual avulsed biopsy, but has 
the advantage, it is painless; it can be used by all doctors-stomatologits, not 
just oral surgeons. It can be used in patients with numerous lesions of the oral 
cavity, as smooth and beneficial to patients who are afraid of normal biopsy.  
A biopsy is the main and most accurate method of diagnosis and 
sometimes of treatment of tumors. Sometimes a biopsy gives wrong results 
(due to non-compliance taking of material or misinterpretation of 
morphological drug). In such cases, it should be carried out repeated studies. 
Cheilostomatoscopy is used for differential diagnosis of precancerous 
lesions and malignant tumors of oral cavity. 
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AI Yatskiv proposed the color test with 1% aqueous blue toluidine 
solution. It is recommended using this test for suspicious areas to determine 
the oral mucosa, and for differential diagnosis of benign and malignant 
tumors. Vital toluidine blue coloration has high sensitivity but low specificity, 
due to accumulation of stain in areas of dysplasia and inflammation. This test, 
according to its information content is similar to immediate biopsy. 
At advanced stomatoscopy it is possible to carry out differential 
diagnosis of precancerous lesions with the initial stages of cancer. 
At the same time, T.S. Dvornikova (2000) has noted that extended 
stomatoscopy results in the diagnosis of precancerous diseases of the oral 
mucosa are not incontestable. Sensitivity of buccal biopsies was 96%, 
specificity - 97%, but for verification of diagnosis it is necessary to do 
avulsed biopsy. Therefore, the effective non-invasive detection of malignancy 
of cancer remains a serious problem. 
 
Fig. 46. Vizilite Plus 
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Chemiluminescent light, based on systems Vizilite Plus, MicroluxDL, 
is used for visualization of pathological processes of oral mucosa, which is 
not visible in normal light bulb. 1% acetic acid is used for rinsing the mouth 
to remove desquamated epithelial cells before the state value of to oral health 
assessment using light. When illuminated normal epithelium absorbs light 
(becomes light blue), while abnormal tissue reflect light (appears white color), 
they can be seen TB blue marking system containing fenotiazin. 
Vizilite Plus, Microlux DL, these competing technologies are very 
similar, they are the best methods to determine areas with high DNA content; 
have a high degree of sensitivity. Disadvantages are low specificity, can 
detect the light conditions of the mucosa, which is not abnormal. These 
technologies are better than visual inspection, but they do not determine the 
true boundaries of the lesion. 
There is a screening system Identafy 3000 ultra for oral mucosa 
precancerous lesions visualization improving, which can not be revealed 
during casual examination. But, unlike other fluorescent technologies and 
supravital color, Identafi is a multispectral system with three different lengths 
and colors waves, that making it easier to diagnose morphological changes in 
lesions, thereby reducing the likelihood of false-positive results. 
Vizilite Plus system uses toluidine blue, for further assistance in 
evaluating oral mucosa lesions. It can detect abnormal areas located under  
mucous membrane and are invisible under normal examination using day 
light from incandescent lamps. According to three studies evaluation system, 
its sensitivity was 100%, the number of positive results was 18-80% 
falsenegative 0-100%.. 
Autoflyuorescent research methods, describe the impact of a specific 
wavelength of the light beam on epithelial tissue, it is expressed excitement 
cellular fluorophores and radiation energy as fluorescence. Within normal 
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tissue morphology disruption in dysplastic lesions fluorescence is collected 
and dispersed, resulting in tissues discoloration.. According to this principle 
Velscope works, a device for mucosa precancerous changes early diagnosis. 
Normal, healthy oral mucosa with this lighting rendered pale - green, while 
the pathological areas - dark because it does not flyuorescenting.. 
It is known from the data of world literature that Velscope is used as 
oral mucosa pathological areas edges auxiliary definition while surgical 
manipulation; as a screening technique for determining the precancerous 
lesions and their early manifestation in the oral cavity. 
According to some authors, the accuracy in determining tissue auto 
fluorescence is 98-100%, 100-78% specificity. 
Typically, the primary method of diagnosis is a visual examination of 
tissue using lamps with white light, but existing design: Velscope, Identafi, 
Vizilite Plus, Microlux and Oral CDx. Scientists around the world continue to 
experiment with modern optical technologies: fluorescence spectroscopy, 
autoflyuorecence imaging, confocal microscopy, optical coherence 
tomography. Unfortunately, all the above-mentioned current screening 
technologies are too expensive for widespread application in Ukraine, making 
the new system unavailable today for dental doctors in public institutions, and 
the more in rural clinics. 
Light curing unit series UFL-122 was invented by local scientific and 
production company Lux Dent. Unit developers have used four light spectrum 
(blue, green, red, orange) (G - to diagnose oral mucosa lesions and etc., O - 
for oral mucosa diseases, deep lesions treating), the unit can be used for caries 
and its complications, oral mucosa and periodontal tissues diseases diagnosis 
and treatment.  
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Transillimination method is formed the basis of unit usage. Learning 
(training), secondary and hidden approximal caries, mouth mucous membrane 
lesions, dental hard tissues lesions diagnosis is possible by means of this unit 
usage. Unit Lux Dent UFL-122 series are used in clinical practice since 
September 1998 and up to date at the Department of Postgraduate Education 
Physicians Dentists HSEEU UMSA.  
The Periodontal and oral mucosa disease dynamics study during 
complex treatment using laser demonstrate improved general condition after 
2-3 treatments   (exacerbation of ulcerative gingivitis).  Good results are 
obtained using R- and O mode with purulent sinusitis, temporomandibular 
mandibular arthritis, lymphadenitis, abscesses and face phlegmon. 
Unfortunately, there is no data in literature on the use of these modes in the 
practice of oral cavity mucous membrane precancerous screening assessment. 
The latest development from american scientists team is painless non-
invasive mouth cavity oncodiagnosis technology creation, as an alternative to 
traditional sampling tissue for histological examination. This nano - biochip, 
like a toothbrush, reqired for diagnoses a few minutes, just touching the 
affected areas of tissue on the tongue, cheeks, throat or mucous of patients. 
Immunohistochemical methods have to establish the localization of 
antigens in specific components of tissues, cell types and cell structures using 
specific antibodies. Currently, mutations in the gene P53 or loss of this gene 
in the chromosome 17p most common genetic abnormality that observed in 
human malignant tumors of epithelial origins (from 40% to 60%). And the 
biggest percentage amounts oral mucosa cancer (60-80%).  
Mutation in the gene expression of P53 and protein p53 is considered 
an initial event in the development of carcinomas in the mouth and 
aerodigestive way and is a measure of pathological phenotype progression 
that has already genetic changes in cells. Protein KI-67 expression level 
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determining can objectively evaluate the epithelial tumor genesis proliferative 
activity.  
Treatment methods depend on the type of precancer, stage of disease, 
they can be therapeutic and surgical, so good results were obtained while use 
Solkovahina and Lizomukoyida as adjuvant therapy of oral mucosa 
leukoplakia (splash and verukosis form). Heliy-neon laser scheme of physical 
treatments of leukoplakia reasonable use is possible.  
Surgical treatment methods (lesion excision within healthy tissue areas, 
cryosurgery, microwave hyperthermia, laser surgery) - used while curing 
Keyer erythroplasia, cutaneous horn, Bowen's disease, papilloma, warty 
precancer restricted hyperkeratosis, verukosis form of leukoplakia, 
keratoakantoma, in case of unsuccessful treatment erosive forms of cheilitis 
and leukoplakia Manhanotti etc. They are performed within a short time after 
diagnosis, but with oral cavity pretreatment. To do this, it is necessary to 
remove the metal construction, replace seals made of metal, sometimes with 
polymers, avoid wearing dentures. Furthermore, it should strictly prohibit 
smoking, chewing tobacco and tabaco mixture, exclude selftreatment.  
For faster healing after surgery is recommended to rinse with the herb 
or their mixtures, oil solution (malavit, stomatofit, stomatofit A), application 
of vitamins A, E, applying ointments, Solcoseryl, under its influence 
diminishes spasm of arteries and arterioles, there is the growth of new 
collateral vessels, improves trophic tissues, increased utilization of oxygen 
content of normal breast and pyruvic acid, increased proliferation and 
migration of fibroblasts, increases collagen synthesis.  
 F.M. Mamedova and co-authors studied Meturakol film (based on 
Methyluracilum collagen) efficiency for the treatment of patients with flat red 
lichen. 
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 R.V. Ushakov and co-authors used a film Dyplen Dent containing  
comprising dexamethasone, lincomycin, chlorhexidine. 
 D.S. Abakarova substantiated soluble films with SOLCOSERYL 
efficiency at various traumatic and inflammatory lesions of the oral mucosa.  
 Within the short term of oral cavity sanation in order to protect the 
lesion with epithelial defect (erosion, ulceration, cracks) symptomatic 
treatment is performed using painkillers, antiseptic and epitelising medicines. 
Primary form of leukoplakia is treated conservatively. It is recommended to 
apply vinilin mixture, 10% metyluratsyl emulsions and oil solution of vitamin 
A in the form of application to 20 minutes for affected areas. In the presence 
of erosions and if they formed recently (10-14 days old), ointments prescribed 
hormones (prednisone, synalar, flutsynar, hydrocortisone, etc.), aekolu oil 
solution application, lubricating ointments patron, calendula, etc.), sea 
buckthorn oil, "Ayekol" "Aevit" and others.  
For erosive and ulcerative hyperkeratosis leave red flap form treatment 
synthetic anti-malarial drugs with small doses of corticosteroids 
(prednisolone, dexamethasone, dermoveyt, advantan) and vitamin B is used. 
Ointments with corticosteroids and others are used fir local applications. In 
evident severe inflammation, for local therapy except  antiseptic and 
keratolytic agents, anti-inflammatory, analgesic, antibacterial and epithelizing 
action medications should be prescribed. These properties have: 1% alcohol 
citral solution, 0.1% sodium salt mefenamin solution, artificial lysozyme, 
Givalex, stomatydyn et al., Decoctions, tinctures and herbal gel and 
combinations thereof; quercetin granules, stomatofit, piralveks and others. 
These medications are used for rinsing baths and oral applications (3-4 times 
a day) as well as sebidyn tablets with vitamin C, trahisan, lisobakt etc.  
Shumsky A.V. recommends to include to precancerous diseases 
complex therapy and perform as to indication the following:  
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- immunomodulatory therapy with glutaksym, thymogen, 
immunofan, derynat, galavit; 
- antioxidant therapy (vitamins A, E, C, selenium medications, 
meksydol); 
- metabolism correcting (vitamins, adaptogens, herbal 
medications).   
   
Oral cavity malignant tumors prevention primary task in Ukraine has 
significant limitations and refusal of alcohol, and promote good nutrition, 
occupational cancer prevention, carcinogenic pollution fighting, prevention of 
exposure to excessive ultraviolet radiation and hereditary caused malignant 
tumors prevention . Because cancer effects of the Chernobyl accident special 
attention requires malignancies due to ionizing radiation primary prevention 
measures.  
Oral mucosa chronic trauma eliminating with teeth sharp edges, poorly 
made dentures, lubricate lips with cream regularly, take vitamin A concentrate 
of 10 drops., 3 times a day within 2 months. 
 When literature analysis summarising first should be noted oral cancer 
diagnosis and treatment complexity problem. Taking into account all known 
developments and successes in this area, yet a significant number of problem 
aspects  remains valid today, and it requires further study and clarification.  
Malignant tumors incidence significant increase is marked within 
recent years, but still most of the patients "appears" in the late stage of the 
disease. This requires complex and expensive treatment and long-term 
outcomes remain unsatisfactory. At the same time, doctors of all specialties in 
their practice regularly meet with patients various localizations latent stages 
cancer carrier.  
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But in most cases, the tumor is detected in the metastatic stage. To 
detect early malignancies physician should have modern ideas about cancer 
development process features.  
Immunohistochemical detection of separate proteins p53 and Ki-67, as 
the latest and modern methods of oral cavity mucous membranes 
precancerous diseases early diagnosis and malignant neoplasms histological 
diagnosis allows us to identify early signs of malignancy in the early stages of 
the disease, and the percentage of the likely degeneration of precancerous 
lesions in malignancy. Malignant tumors process development patterns 
knowledge will facilitate early detection of tumors and more effective 
treatment. 
 It is important to perform oral cavity mucous membrane precancerous 
diseases and cancer screening by the dentist during regular outpatient 
examination. Fot this purpose we believe that appropriate is the use of localy 
manufactured unit UFL-122 Lux-dent company, for diagnosing oral mucosa 
and lips diseases, periodontal (G -Mode) and for treatment of these 
conditions, along with traditional treatment methods.  
Relevant upto today is the use of congratulatory painting suspicious 
sites oral cavity and lips red border mucous membrane with 1% toluyidyn 
blue solution, marking clear boundaries pathological lesion for subsequent 
extensive biopsy, etc.  
This method of malignancy early detection is available to all dentists 
and informative diagnosis metho, easy to use, almost having no 
contraindications, except for hypersensitivity to product components. 
 In processed literature there is no data on the use of localy 
manufactured unit UFL-122 Lux-dent company in different spectra of light 
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for oral mucosa and lips precancerous diseases diagnosis and early detection - 
modes ("O" and «R») - as part of its comprehensive treatment.  
That is why we consider appropriate to examine and investigate more 
thoroughly its diagnostic and therapeutic effect.  
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ORAL CAVITY PRECANCEROUS STATES AND CANCER 
HISTOLOGICAL DIAGNOSTIC OBJECTIFICATION BY 
BIOMARKERS P-53 AND KI-67 ON BIOPSY MATERIAL 
 
 
 Oral cancer constitutes about 3% of all cancers and is a major 
worldwide health problem. Despite significant progress in methods of 
treatment, 5-year survival rate has not improved over the last few decades 
and is still about 50-60%. More than 80% of oral cavity cancers are 
squamous cell carcinoma, which develops from the epithelium through the 
progression from hyperplasia to dysplasia and carcinoma in citu and further 
on to invasive cancer. A significant proportion of squamous cell carcinoma 
develops from premalignant damages.  
Despite oral cavity availability for clinical examination, a large 
percentage of tumors are diagnosed at no precancerous states, but at the last 
stages of the disease. Oral mucosa cancer early detection is critical for 
treatment, because survival terms are significantly improved if oral mucosa 
pathology is qualified diagnosed and detected at an early stage. It should be 
specified that oral mucosa premalignant conditions and early cancer 
occurring mostly asymptomatic. Oral mucosa precancerous states significant 
percentage can be detected not only by oncologists and dentists, ENT 
doctors during oral cavity examination in patients treated with their disease 
profile. 
Currently, mutations in the gene p53 or loss of this gene in the 
chromosome 17r most common genetic abnormality that observed in human 
malignant tumors of epithelial origin (from 40% to 60%). And the biggest 
percentage amounts oral mucosa cancer (60-80%). Suppressor gene 
product p53 main function in tumor growth in the cell is in the regulation of 
normal cell proliferation, and genes involved in DNA repair when it is 
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damaged transcription activation, and apoptosis regulation. Mutations in the 
p53 gene and overexpression of p53 protein are being considered a primary 
event in the development of carcinomas in the mouth and aerodigestive way 
and are a measure of pathological phenotype progression that has already 
genetic changes in cells. The protein Ki-67 protein belongs to the cell cycle 
regulators. 
Fig. 47. Papilloma area photomicrograph. Diagnosis: papillomatosis (left 
maxillary sinus blastoma). Single CI-67 in the epithelium. 
Immunohistochemical reaction with KI-67. Hematoxylin-eosin colored. 
Histological sample No. 49895/08. Enl.×1000.  
 
Tumor cell growth rate is a key characteristic that determines the 
tumor aggressiveness. Determining Ki-67 protein level expression can 
objectively evaluate epithelial origin tumors proliferative activity. In order 
to prevent oral mucosa precancerous conditions degeneration, multiple 
address screening methods for risk groups (smoking combined with 
alcohol abuse, professional prolonged contact with mutagens and 
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carcinogens) are required to detect precancerous conditions and 
objectification diagnostic methods using modern definition technologies 
biomarkers that precede cancer development.  
Cells with expression p53 and Ki-67 performed analysis revealed 
individual characteristics as in the expression levels of biomarkers studied, 
and their distribution in the examined observations. Thus, among 
histologically defined papillomatosis (squamous papilloma) in the mucous 
marked difference in the expression of p53 and Ki-67. One observation has 
the slight signs of dysplasia (low), where cells with p53 were not found, only 
solitary cells with Ki-67 in hyperplastic papillomatous epithelium separate 
fields were noticed. 
 
Fig. 48. Papilloma area photomicrograph. Diagnosis: papillomatosis with 
malignancies (left maxillary sinus tumor). Average dysplasia. P53 cells in 
epithelium basalis, parabasalis layers. Immunohistochemical reaction wioth 
p53. Hematoxylin-eosin colored. Histological sample No. 49891 - 2/08. 
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 The second observation shows stratified squamous epithelium 
papillomatous proliferation cells with dysplasia signs and p53 expression in 
cells in the zone of proliferating cells, in suprabazalis layer cells directly 
parabasalis layer of epithelial cells. In some papillomatous outgrowths areas 
single cells with p53 in basal and parabasalis cell layer and in the surface 
layers and suprabazalis cells expressing Ki-67 in field cages with signs of 
dysplasia were found. Cells with p53 and Ki-67 labeling index (LI) was 
29.6% with range in individual fields from 19% to 42% and 17.2% with 
range of 10% -24%, respectively.  
Fig. 49. Mucosal area photomicrograph. Diagnosis: Mouth bottom 
mucous membrane cancer. Histological sample No. 37437/08. Single KI-67. 
Dysplasia (low). Immunohistochemical reaction with KI-67. Hematoxylin-
eosin colored. Enl.×1000.  
 
It should be noted that dysplasia in this observation morphological 
was the low level, subjectively at the secondary level, but the definition of 
essential cells with p53 in cells, and particularly suprabazalis surface layers 
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and proliferating cells of Ki-67 gave reason to decide in favor of 
malignancy.  
This observation demonstrates how determined biomarkers examination 
and its topography allow histologist to get rid from subjective evaluations 
while diagnosis and objectify individual diagnostics.  
Fig. 50. Lower lip red border area photomicrograph. Clinical diagnosis: 
Lower lip red border hyperkeratosis. Histopathological diagnosis: 
leukoplakia (high dysplasia). Histological sample No. 24134. 
Immunohistochemical reaction with p53. Hematoxylin-eosin colored. Enl. × 
1000.  
 
Among surveyed leykoplakias in one observation cells were detected 
with neither p53 nor with Ki-67, indicating a relatively quiet epithelium 
conditions in biopsy material of this leukoplakia. The second observation 
was diagnosed with leukoplakia signs of dysplasia and cell proliferation 
basal cells and a significant level cells with p53 (LI 24.6%, range 12% -
33%) and Ki-67 (14.5% LI, range 6% -21%, respectively), which may 
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indicate a breach gene p53 tumor suppressor and its protein p53, leading 
to disturbances in the normal regulation of cell proliferation, DNA repair 
and apoptosis. This is evidenced by the marked proliferation of 
epithelium basal layer cells and a certain level of proliferating cells in 
this leukoplakia. 
The literature has accumulated historical data about such leykoplakias  
malignancy and cancer development from them after a certain period of 
time and such leukoplakias require monitoring after performed treatment.  
Fig. 51.  Lower lip red border areas photomicrograph. Clinical 
diagnosis:  Lower lip red border suspected cancer. Histopathological 
diagnosis: Epithelium high dysplasia. Intraepithelial carcinoma. 
Histological sample No. 5697/04. An intense expression of p53. 
Immunohistochemical reaction with p53. Hematoxylin-eosin colored. 
Enl. × 1000.  
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Among diagnosed mucosa epithelium dysplasias in one observation 
with small cell dysplasia squamous epithelium (dysplasia low to medium) 
cells with p53 and Ki-67 was not found.  
The second observation squamous multylayred epithelial with 
dysplasia margins (low) isolated cells with p53 with very weak 
immunoexpression were revealed (LI 1% range 1-2%) and single cells 
expressing Ki-67 (LI 0.4% range 0 -2%).  
For the third observation, within which cytomorphologically 
multilayred squamous epithelium with signs of dysplasia (average) was 
found, in a large segment of histological sections within 
immunohistochemical study cells with high p53 and Ki-67 (p53, LI 
44.9%, range 35-55%, Ki-67, LI 27.5%, range 20-34%, respectively) were 
identified. Specific for this observation were placed, without merging with 
each other, isolated groups of cells that look like clones of individual cells 
with intense expression of p53 in suprabasalis epithelial layers.  
According to the literature, founded p53 suprabasalis immuno 
expression is clearly associated with the degree of such dysplasia and 
malignancy risk of dysplasia manifestation. 
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Table 1. 
Histopathological diagnosis  and cells level with p53 and Ki-67 examined 
biopsies distribution.   
Pos. 
No 
 
Biopsy 
No. 
Clinical diagnosis 
Histopathological 
diagnosis 
р53  
(LI %) 
Range 
Кі67 
(LІ %) 
Range 
1 2 3 4 5 6 
1 
49895/
08 
Left maxillary sinus 
blastoma 
Papillomatosis 0,0 
0,2 
0-2 
2 
49891-
2/08 
Left maxillary sinus 
tumor 
(В1) 
Papillomatosis 
with malignancies 
(average dysplasia) 
 
29,6 
19-42 
 
17,2 
10-24 
3 
13743/
04 
Tongue lateral 
surface leukoplakia  
 
Leukoplakia  0,0 0,0 
4 24134 
Lower lip red border 
hyperkeratosis 
Leukoplakia 
(high dysplasia) 
 
24,6 
12-33 
14,6 
6-21 
5 
29118-
20 
Lower lip red border 
separated 
hyperkeratosis  
 
Epithelium 
dysplasia 
(low) 
 
0,0 0,0 
6 
4814/0
4 
Palate mucosa 
cancer 
Epithelium 
dysplasia (high) 
44,9 
35-55 
27,5 
20-24 
7. 
37437/
08 
Mouth floor mucosa 
cancer 
Epithelium 
dysplasia 
(low) 
 
1,0 
1-2 
(weak 
expression 
in single 
cells) 
0,4 
0-2 
8. 
5697/0
4 
Possible lip cancer 
Epithelium 
dysplasia (high), 
intraepithelial 
carcer 
 
8,0 
2-6 
8,4 
5-12 
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9. 
48891-
2/08 
Possible mouth floor 
mucosa cancer 
Epithelium 
dysplasia (high), 
intraepithelial 
carcer  
34,9 
10-60 
1,5 
1-2 
10. 
20539/
04 
Possible lip cancer 
Epithelium 
dysplasia (high), 
intraepithelial 
carcer  
69,2 
62-77 
9,6 
7-12 
11. 
44888/
08 
Mouth floor mucosa 
area with 
postradiation 
cicatricial tissue 
Squamous cell 
cancer remains with 
tumor cells 
penetration into 
granulocytic tissue 
3,1 
1-6 
1,7 
1-7 
12 
35951/
05 
Soft palate mucosa 
cancer 
Squamous cell 
cancer  
1,0 
0-3 
1,0 
1-2 
13 
49839/
08 
Possible lip cancer 
Squamous cell 
cancer 
3,75 
0-15 
8,1 
3-26 
14 
4812/0
4 
Hard palate mucosa 
cancer 
Squamous cell 
cancer 
15,5 
6-32 
0,4 
0-2 
15 
30059/
04 
Mouth floor mucosa 
cancer 
Squamous cell 
cancer 
27,6 
13-59 
7,8 
5-14 
16 
30058/
04 
Mouth floor mucosa 
cancer 
Squamous cell 
cancer 
39,3 
28-47 
16,3 
0-48 
17 
49893/
08 
Left maxillary sinus 
tumor piece  
Squamous cell 
cancer 
34,5 
16-45 
16,4 
4-26 
18 
4603/0
4 
Possible lip cancer 
Squamous cell 
cancer 
30,4 
21-45 
4,2 
0-9 
19 
49894/
08 
Left maxillary sinus 
tumor piece 
Squamous cell 
cancer 
18,1 
2-38 
10,8 
6-23 
20 
4602/0
3 
Possible lip cancer 
(В1) 
Squamous cell 
cancer 
23,4 
10-43 
22,3 
10-43 
21 
29120/
04 
Lower lip red border 
local hyperkeratosis  
Squamous cell 
cancer 
15,3 
9-22 
13,2 
7-22 
22 
19406/
0 
4 
Possible lip cancer 
Keratinizing 
squamous cell 
carcer 
0,0 0,0 
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Intraepithelial carcer (3-rd observation) was also diagnosed with cells 
p53 and Ki-67 involvement to histological level characteristics in these 
observations. 
For two observations typical were high performance dysplasia and 
examined studied biomarkers values (p53, LI 69.2%, range 62% -77% and 
LI 29.6%, range 19-42%, Ki-67, LI 9.6% range 7-12% and 17.2% LI, 
range 10-24%, respectively for these two observations in stratified 
squamous epithelium areas with signs of cells dysplasia with high p53 and 
Ki-67 prevailed in the superficial suprabasalis epithelium layers. In one 
observation high dysplasia is marked by cytomorphological signs in 
stratified squamous epithelium, but with not significant levels of cells with 
p53 and Ki-67 (p53, LI 8.0%, range 2.6%, Ki-67, LI 8.4%, range 5-12%, 
respectively).  
But determined expression of these proteins in surface suprabasalis 
epithelium layers of cell nuclei and significant proliferating cells indicator as 
well at surface suprabasalis layers level where naturally proliferating cells 
are almost absent (in some areas their level reached 12%) allowed in the  
examined biopsy material to diagnose not a dysplasia but intraepithelial 
carcer.  
This observation clearly demonstrates how by means of p53 and Ki-67 
biomarkers immunohistochemical examination on biopsy material 
histopathological changes in mouth mucosa can be objectively diagnosed.  
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Fig. 52. Mouth floor mucosal areas photomicrograph. Clinical diagnosis: 
Mouth floor mucosal possible cancer. Histopathological diagnosis: High 
dysplasia. Intraepithelial carcer. Histological sample No. 48891-2 / 08. p53 
intense expression. Immunohistochemical reaction with p53. Hematoxylin-
eosin colored. Enl. × 1000.  
 
According to the study, using histological analysis potential cancer 
threat in the mucosal precancerous conditions can be determined, but its 
further biological behavior is not possible to predict. However, investigated 
p53 and Ki-67 biomarkes expression determination allows to get objective 
approach to precancerous condition individual dysplasia level assessment 
and subsequent treatment strategy. 
Among biopsies (12 observation), where oral mucosa squamous cell 
carcer was cytomorphologicaly diagnosed individual characteristics were 
found also as in studied biomarkers expression levels, and their distribution 
in the investigated tumors, allowing to make their malignancy and 
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proliferative potential individual assessment. Thus, in one observation where 
keratinizing cancer was diagnosed, cells with p53 and Ki-67 were not 
revealed. Squamous cell cancer observations exist when mutated gene 
protein p53 immunohistochemicaly can not be detected in tumor cells, but 
this does not exclude mutations in the p53 gene. 
 
 
Fig. 53. Hard palate mucosa areas photomicrograph. Clinical diagnosis: 
Hard palate mucous membrane cancer. Histopathological diagnosis: High 
epithelial dysplasia. Histological sample No. 4814-2 / 04. p53 intense 
expression. Immunohistochemical reaction with p53 and Ki-67. 
Hematoxylin-eosin colored. Enl. × 1000. 
 
Two observations identified cancer cells with low levels of 
biomarkers examined, which in one case was due to the fact that the 
histological sections for immunohistochemistry did not get tumor 
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essential part cut (p53, LI 1% range 0-3% Ki-67, LI 1% range 1.2%, 
respectively) and the second observation p53- LI 3.75%, but range in 
the level of p53 in tumor cells examined fields from 0 to 15% and with 
significant level of cell with Ki- 67 (LI, 1% range 3-26%). 
In one observation diagnosed with squamous cell oral mucosa 
cancer after radiation (biopsy tissue scar after radiation) among 
granulation tissue field epithelial cells with signs of radiation 
pathomorphosis and fields of cells with signs of dysplasia (high) were 
detected and immunohistochemistry identified cells with p53 (LI 3 1% 
range 1 - 6%) and Ki-67 (MI 1.7%, range 1% -7%).  
Tumor cells with p53 saving, which has significant maligncies and 
proliferating cells including demonstrates tumor recurrence in the scar area 
possibility formation after radiation exposure. This observation 
demonstrates an opportunity within immunohistochemical examination of 
cells with p53 and Ki-67 more accurately assess mucosa condition after 
received treatment. In other squamous cell carcer observations (9 
observation) LI cells with p53 fluctuated in the range of 15.3% to 39.3%, 
and LI cells with Ki-67 was in the range of 0.4% to 22.3%, respectively.  
Molecular biomarkers p53 and Ki-67 high expression level in oral 
cavity squamous cell carcer indicates these tumors high malignant potential. 
The level of tumor cells with p53 is determining individual biomarker of 
oral cavity malignant squamous cell carcer assessment.  
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Fig. 54. Hard palate mucosa areas photomicrograph. Clinical diagnosis: 
Hard palate mucous membrane cancer. Histopathological diagnosis: High 
epithelial dysplasia. Histological sample No. 4812/04. Ki-67 intense 
expression. Immunohistochemical reaction with Ki-67. Hematoxylin-eosin 
coloured. Enl. × 1000. 
 
Thus, cells level with p53 and Ki-67 on biopsy material oral mucosa 
precancerous conditions and cancer performed analysis shows that the use of 
immunohistochemical technologies  protein gene suppressor tumor growth 
p53 and protein proliferating cells Key 67 determining while histological 
diagnosis allows us to give more objective assessment of individual 
processes that occur in oral mucosa precancerous conditions, evaluate 
malignancy risk, proliferative potential and predict tumor malignancy. 
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